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Both body axes of the Drosophila egg are determined by localization of several 
mRNAs to specific regions within the oocyte. One of these mRNAs, oskar (osk), is 
required for posterior body patterning. Localization and translational control are both 
crucial for the correct deployment of osk. Bruno (Bru) binds specifically to the 3’UTR of 
the osk mRNA and represses osk translation. In this dissertation, I first describe a genetic 
screen looking for dominant modifiers of the arrest (aret) mutant phenotype (aret 
encodes Bru). Two modifiers suggested additional targets for Bru action. One is Star, a 
gene that contributes to provision of Gurken activity. The second suggested target is a 
gene acting in the Delta signaling pathway. A final modifier, Lk6, encodes a protein 
kinase predicted to regulate eIF4E. I also took a biochemical approach trying to 
understand how Bru regulates osk translation. Bru protein contains three RNA 
Recognition Motifs, but the remainder of the protein had no known function. I identified 
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a domain, which is required for interaction to Bru itself, Cup and Apontic. Subsequent 
analysis of mutant forms of Bruno defective in these interactions led us to an unexpected 
discovery that Bru also acts as an activator of osk translation. Parallel analysis of Bru 
binding sites in osk 3’UTR fully support the notion that Bru has a dual role. There are 
two clusters of Bru Recognition Elements in either end of osk 3’UTR. Point mutations in 
one cluster cause overproduction of Osk protein while point mutations in the other cluster 
largely prevent translation of the message. To understand the molecular basis of the 
opposing roles of Bru, I used quantitative methods to better define and compare the 
binding of Bru to the different regulatory elements: those that either repress or activate 
osk mRNA translation. Using purified components I found that Bru binds to two clusters 
of binding sites in the osk 3’UTR differently, in terms of affinity, cooperativity and 
apparent compaction of the RNA. This work raises the possibility that the details of how 
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Chapter 1: General Introduction 
This thesis is about post-transcriptional gene regulation during early development 
of Drosophila melanogaster. Both anteroposterior (AP) and dorsoventral (DV) body 
plans of the Drosophila egg are determined by localization of several mRNAs to specific 
regions within the oocyte (Davidson, 1986; Riechmann and Ephrussi, 2001; van Eeden 
and St Johnston, 1999). One of these mRNAs, oskar (osk), is required for posterior body 
patterning. osk mRNA is first synthesized very early in oogenesis, but Osk protein only 
accumulates later, after correct localization of the mRNA to the posterior pole of the 
oocyte (Ephrussi et al., 1991; Kim-Ha et al., 1995; Kim-Ha et al., 1991). Ectopic 
activation of osk causes severe disruption of the anterior body plan (Ephrussi and 
Lehmann, 1992; Smith et al., 1992). Therefore, precise regulation of when and where 
Osk protein is made is crucial for correct patterning along the AP axis. A number of 
proteins have been shown to be important for localization or translational control of the 
osk mRNA. The first protein identified to play a role in osk translational control is Bruno 
(Bru). Bru binds specifically to the 3’UTR of the osk mRNA and represses osk translation 
(Castagnetti et al., 2000; Kim-Ha et al., 1995; Lie and Macdonald, 1999a; Webster et al., 
1997). There are two major aims of research presented in this thesis. One is to determine 
the mechanisms by which Bru regulates osk translation, and the other is to identify 
additional mRNA targets of Bru and factors that may act upstream or downstream of Bru 
in the same pathway. 
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MATERNAL CONTRIBUTION IS ESSENTIAL FOR THE DEVELOPMENT OF THE EGG AND 
EARLY EMBRYO. 
Maternal supply accumulates during oogenesis 
Early animal development is controlled by maternally encoded RNAs and 
proteins, which are loaded into the egg during oogenesis (Davidson, 1986). When the 
eggs are laid, they can use those RNAs and proteins for general maintenance of the 
embryo to survive in the external environment until zygotic transcription begins, as well 
as for regulation of specific developmental processes in the embryo.  
Oogenesis takes place in the female gonad, the ovary, and is the process of egg 
production. There are three cell types in the Drosophila ovary: oocyte, nurse cell and 
follicle cell. A typical Drosophila ovary contains 16-20 ovarioles. Each individual 
ovariole is composed of a string of progressively more mature egg chambers (King, 
1970). In each egg chamber, one oocyte is connected to 15 nurse cells via cytoplasmic 
bridges called ring canals. Nurse cells synthesize large amount of RNAs and other 
cytoplasmic molecules that are transferred through the ring canals into the oocyte. Both 
oocytes and nurse cells are germ line cells, while follicle cells are somatic cells that 
surround the germ line cells. With the cytoplasmic contents provided largely by nurse 
cells during oogenesis, the oocyte becomes polarized while growing in size and 
eventually becomes an egg. Some of the contents of an egg are asymmetrically 
distributed before fertilization. This asymmetrical distribution is important for 
establishing the future body plan (Riechmann and Ephrussi, 2001; van Eeden and St 
Johnston, 1999). 
Maternally supplied factors are involved in body patterning 
Some factors supplied by the mother have important regulatory roles in body 
patterning (van Eeden and St Johnston, 1999). These maternal factors are often 
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concentrated in particular regions of the egg. Following many rounds of cell divisions 
during development, they are inherited only by subsets of cells. Asymmetric distribution 
of these maternal factors allows them to either promote or suppress subsequent cellular 
events in certain regions, thus leading to the formation of future body pattern.  
Many maternal-effect genes have been identified genetically that are required for 
specifying the body pattern (Frohnhöfer and Nüsslein-Volhard, 1986; Lehmann and 
Nüsslein-Volhard, 1986; Schüpbach and Wieschaus, 1986; Schüpbach and Wieschaus, 
1989). When these gene products are missing in the mother, the embryos produced 
display an abnormal body pattern. Some of these genes are acting in the same pathways, 
since loss-of-function mutants of these genes display similar defects (Schüpbach and 
Wieschaus, 1989). A small subset of these maternal patterning genes have special 
properties, and are called spatial determinants. The determinants are localized to specific 
regions of the egg or embryo, are required for patterning of that region, and can 
reprogram patterning if present at other regions (Driever et al., 1990; Ephrussi and 
Lehmann, 1992; Frohnhöfer et al., 1986; Gavis and Lehmann, 1992; Webster et al., 
1994). 
The osk gene encodes a posterior body patterning determinant (Lehmann and 
Nüsslein-Volhard, 1986). If the mother is homozygous mutant for osk, the embryos 
produced are defective in posterior patterning and have no abdominal segments. There 
are many other mutants that can give a similar phenotype. What sets osk apart from other 
genes involved in posterior body patterning is that osk has the ability to direct this 
patterning process. For example, when the mothers either have too much osk or have 
mislocalized osk, this ectopic osk activity reprograms anterior-posterior patterning and 
causes the loss of anterior structures. In strong cases, a mirror image of the posterior can 
form at the anterior and result in a symmetrical cuticle phenotype called bicaudal 
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(Ephrussi and Lehmann, 1992; Gavis and Lehmann, 1992; Smith et al., 1992). Because of 
this strong patterning activity of osk, careful regulation has to be in place to restrict osk 
activity to the posterior. 
LOCALIZATION AND TRANSLATIONAL CONTROL OF THE OSK MRNA RESTRICT OSK 
ACTIVITY TO THE POSTERIOR 
mRNA localization is a process that is prominently used in fly ovaries (St 
Johnston, 1995). Localization of mRNAs allows specific proteins to be synthesized in the 
subcellular regions where their activities are required and avoids regions where their 
expression is not desirable.  
osk localization 
osk mRNA appears very early in oogenesis and is concentrated in the oocyte 
cytoplasm. It becomes restricted to the posterior pole of the oocyte at stage 8/9, and 
remains there until early embryogenesis (Ephrussi et al., 1991; Kim-Ha et al., 1991). The 
localization process involves the movement of the transcripts first into the oocyte from 
adjacent interconnecting nurse cells where the transcripts are made, and then across the 
length of the oocyte to the posterior pole. There is a transient appearance of the osk 
mRNA at the anterior boundary of the oocyte at stage 8, indicating that anterior 
accumulation is an intermediate step of the osk localization process. 
Localized mRNAs often contain cis-elements in the 3’UTR that are required for 
localization (Johnstone and Lasko, 2001). In Drosophila, a number of maternal mRNAs 
have well characterized localization signals. Taking bicoid as an example, it is required 
for anterior body patterning and its mRNA localizes specifically to the anterior of the 
oocyte (Berleth et al., 1988; Driever and Nüsslein-Volhard, 1988; Frohnhöfer and 
Nüsslein-Volhard, 1986). The 3’UTR of bicoid mRNA contains 5 stem-loops (I-V), of 
which IV/V is sufficient for anterior localization in the ovary (Macdonald, 1990; 
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Macdonald and Kerr, 1997). The osk localization signal is more complex, in part because 
there is no strongly predicted secondary structure of the 3’UTR. Several elements were 
identified in the osk 3’UTR that are required for each of 3 different steps of localization: 
early transport into the oocyte, transient anterior accumulation and posterior localization 
(Kim-Ha et al., 1993). However, these elements have not been narrowly defined, and 
their properties remains largely uncharacterized. 
The polarized microtubule network, which extends from nurse cells to the oocyte, 
mediates the bulk of osk mRNA transport during early stages of oogenesis (Brendza et 
al., 2000; Clark et al., 1994; Pokrywka and Stephenson, 1995; Theurkauf et al., 1992). 
Staufen is a protein that is made in nurse cells and colocalizes with the osk mRNA to the 
posterior pole of the oocyte where osk mRNA is anchored with the help of Osk protein, 
Staufen and BicD (Ephrussi et al., 1991; Kim-Ha et al., 1991; Micklem et al., 2000; 
Rongo et al., 1995; St Johnston et al., 1991; Swan and Suter, 1996; Vanzo and Ephrussi, 
2002). Translation of the osk mRNA starts after the mRNA is localized at the posterior 
(Kim-Ha et al., 1995; Markussen et al., 1995; Rongo et al., 1995). The osk mRNA 
encodes two overlapping proteins, Long Osk and Short Osk, using alternative in-frame 
start codons (Markussen et al., 1995; Rongo et al., 1995). Long Osk anchors both mRNA 
and Short Osk at the posterior cortex of the oocyte (Vanzo and Ephrussi, 2002). Short 
Osk is required for the activity of osk in two important developmental processes, each at 
a different dosage level (Breitwieser et al., 1996; Markussen et al., 1995). A low level of 
Osk is required for directing posterior body patterning and a high level of Osk is required 
for pole plasm formation (Markussen et al., 1995; Rongo et al., 1995). Both of these 
processes depend on correct localization of osk mRNA: specific localization restricts osk 
activity to the posterior where it is required for posterior body patterning; localization 
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also provides positional information for pole plasm formation, which specifies the future 
germline (Ephrussi et al., 1991; Kim-Ha et al., 1991; Vanzo and Ephrussi, 2002). 
The osk mRNA is concentrated in the oocyte throughout oogenesis while Osk 
protein is clearly absent at early stages (Kim-Ha et al., 1995; Markussen et al., 1995; 
Rongo et al., 1995). It is only when the osk mRNA is localized to the posterior pole of the 
oocyte at stage 8 that the Osk protein is detectable. By comparing the distribution of the 
osk mRNA and the Osk protein throughout oogenesis, one can easily tell that localization 
of the osk mRNA alone is not sufficient to restrict Osk activity to the posterior. 
Unlocalized osk mRNA has to be translationally repressed or the nascent Osk protein has 
to be quickly degraded to prevent ectopic accumulation of Osk protein. Furthermore, this 
negative regulatory mechanism must be limited temporally. It has to be in place from 
very early in oogenesis and be removed or overcome after localization of the mRNA is 
completed to then allow the protein to accumulate at the posterior. This tight coupling of 
localization and translational control is crucial for the deployment of osk (Ephrussi and 
Lehmann, 1992; Kim-Ha et al., 1995; Markussen et al., 1995; Rongo et al., 1995; Smith 
et al., 1992). 
osk translational regulation 
Two approaches were taken by various researchers to identify genes that play a 
role in translational regulation of osk. Genetically, one can look for mutants that will 
allow Osk to appear precociously. Alternatively, one can rely on biochemical analysis to 
see which protein(s) bind to the osk mRNA, and then determine if such a protein is 
required for localization or translational control. 
The biochemical approach succeeded first and led to the discovery of a protein 
called Bru (Kim-Ha et al., 1995). Bru was identified in an UV crosslinking assay as an 
ovarian RNA binding protein that binds to the osk 3’UTR. There are two discrete regions 
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in the osk 3’UTR that Bru recognizes specifically: the AB region is located shortly after 
the coding sequence and the C region close to the poly(A) tail. Both of these regions 
contain multiple repeats of Bru Response Elements (BREs), U(G/A)U(A/G)U(G/A)U. 
Point mutations in the BREs abolish Bru binding. 
Genetic analysis has also led to the identification of several other genes that are 
also involved in translational regulation of osk (Chang et al., 1999; Cook et al., 2004; Lie 
and Macdonald, 1999b; Micklem et al., 2000; Nakamura et al., 2001; Nakamura et al., 
2004; Saffman et al., 1998; Wilson et al., 1996; Yano et al., 2004). Regulation can be 
negative or positive. I will introduce factors that are involved in negative regulation of 
osk translation first, including Bru and several other gene products. Then I will introduce 
another protein, Orb, which is involved in positive regulation of osk translation 
(Castagnetti and Ephrussi, 2003; Chang et al., 1999). 
Bru and other gene products repress osk translation  
To investigate what role Bru may play in the deployment of osk, a genomic osk 
transgene was made with mutations in all BREs in the 3’UTR to prevent Bru from 
binding and look for osk expression in the absence of Bru regulation (Kim-Ha et al., 
1995). osk with such a mutant 3’UTR is transcribed and localized properly but the Osk 
protein accumulates abnormally: the Osk protein appears precociously throughout the 
oocyte cytoplasm during stage 7/8 and returns to normal (restricted at the posterior pole) 
as oogenesis proceeds, indicating that the mutant mRNA is partially translationally 
unregulated. Thus the Bru binding sites in the osk 3’UTR are crucial for translational 
repression of osk. A more direct form of evidence suggesting that Bru is a translational 
repressor came from studies carried out using an in vitro translation system with 
Drosophila embryo extract (contains no Bru) and purified Bru protein. A luciferase 
reporter RNA bearing a wild type osk 3’UTR is translationally repressed by Bru, while 
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the same reporter RNA bearing BRE mutant versions of the osk 3’UTR is unregulated 
(Castagnetti et al., 2000; Lie and Macdonald, 1999a). Both in vivo and in vitro evidence 
clearly demonstrate that Bru is required for translational repression of osk, and it does so 
by binding to the BREs in the 3’UTR.  
In order to see if loss of Bru function will unleash osk translation in early stage 
oocytes, females carrying mutations in the gene that encodes Bru were analyzed. Cloning 
of the gene (Webster et al., 1997) revealed that it corresponds to the arrest (aret) gene, 
for which multiple mutations had been isolated (Schüpbach and Wieschaus, 1991). aret 
mutants have pleiotropic phenotypes, ranging from an early arrest of oogenesis to 
irregular embryonic segmentation defects (Schüpbach and Wieschaus, 1991; Webster et 
al., 1997). Neither intermediate nor weak aret mutants produce precocious Osk protein 
during oogenesis or show any body patterning defect in progeny embryos that could be 
associated with osk overexpression (Ephrussi and Lehmann, 1992; Smith et al., 1992). 
Strong aret mutants arrest oogenesis at a stage when the oocyte has not yet been 
specified, preventing detection of osk expression. Since aret mutants do not show an 
obvious defect in osk expression, and with extensive evidence supporting the conclusion 
that Bru represses osk translation, one needs to use other means to investigate how Bru 
function.  
One approach is to study other proteins that Bru interacts with. Apontic (Apt) 
interacts with Bru in the yeast two-hybrid system and in vivo (Lie and Macdonald, 
1999b). Embryos produced by females trans-heterozygous for aret and apt mutations 
exhibit anterior patterning defects. This phenotype can be suppressed by reduction of 
nanos, suggesting that it is caused by ectopic Osk. This genetic evidence suggests that 
Apt also has a role in regulating osk translation. Although Apt binds to the AB and C 
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regions of the osk mRNA 3’ UTR, as does Bru, the binding of Apt is not as specific as it 
also binds to other sequences. 
Another protein that interacts with Bru is Cup. The discovery of Cup is quite 
exciting because it leads to a model for Bru-dependent repression of osk translation 
(Nakamura et al., 2004; Wilhelm et al., 2003). The model suggests Bru-mediated 
repression happens at the level of initiation. Initiation is the rate-limiting step of 
translation, and therefore is often the target of many regulatory mechanisms (Gingras et 
al., 1999; Gray and Wickens, 1998). In cap-dependent translational initiation, the 5’ cap 
structure of the mRNA attracts the eukaryotic initiation factor complex, eIF4F, to the 
mRNA. This complex contains the cap-binding protein eIF4E and the scaffold-like 
protein eIF4G. eIF4E binds to the 5’ cap of the mRNA while eIF4G recruits the 40S 
ribosome subunit through eIF3. Translation initiation occurs when the eIF3-40S complex 
is recruited to the 5’ end of the mRNA through an eIF4E-eIF4G-eIF3 interaction. The 
link between eIF4E and eIF4G is a key to translation initiation, and is a crucial target for 
repression. Initiation is disrupted by many eIF4E binding proteins (4E-BPs), which 
complete with eIF4G for binding to eIF4E and disrupt the eIF4G-eIF4E link (Gingras et 
al., 1999). The most relevant example is Maskin, which can be recruited to the 3’UTR of 
specific mRNAs and compete with eIF4G for binding to eIF4E (Mendez and Richter, 
2001). Cup also contains a conventional eIF4E-binding domain and it can also act as an 
4E-BP. In addition, Cup directly interacts with Bru (Nakamura et al., 2004). The model is 
that Cup can be recruited to the osk 3’UTR by Bru, where it binds to eIF4E and prevents 
it from binding to eIF4G. Due to local depletion of eIF4E, the initiation of osk translation 
is disrupted. Consistent with this model, cup mutant females display premature Osk 
expression at stage 6/7 and abnormal Osk distribution at stage 8/9. Cup may have 
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additional functions besides regulating osk, as strong cup mutants show defects in early 
oogenesis, which cannot be due to ectopic Osk. 
Multiple repressive mechanisms are arranged both spatially and temporally to 
achieve precise regulation of osk translation. An example of spatial arrangement includes 
a protein called Me31B, which associates with the same RNP particles containing Cup, 
Bru, eIF4E and many maternal RNAs including osk (Nakamura et al., 2001; Wilhelm et 
al., 2000). me31B mutants display precocious Osk accumulation mostly in early stage 
nurse cells, as opposed to the oocyte accumulation of Osk observed in cup mutants, 
indicating that Me31B represses osk translation primarily in nurse cells. Bru/Cup 
mediated repression may be primarily required in the oocyte. This sequential arrangement 
demonstrates that multiple mechanisms are involved in repressing osk translation, and 
they can be arranged spatially to prevent ectopic Osk accumulation. For example, 
different parts of the osk RNP complex can repress osk expression at different segments 
of the transit. Alternatively, the osk RNP complex can change its composition along the 
transit, with some core component always associating with osk mRNA and other 
auxiliary factors present only when they are needed. 
Not only is osk translation regulated spatially, it is also regulated temporally 
during oogenesis. Osk expression is repressed at all early stages prior to stage 8/9, but 
disruption of Bru/Cup mediated repression only depresses expression during stages 6-8 
(Kim-Ha et al., 1995; Nakamura et al., 2004), which leaves the possibility that an 
alternative mechanism is required for repressing osk during at earlier stages. Indeed, other 
factors have been shown to regulate osk silencing during stage 1-6 (Cook et al., 2004). 
These factors that act early on osk are components involved in the RNAi pathway 
(Aravin et al., 2001; Findley et al., 2003; Kennerdell et al., 2002). armi, spn-E, mael and 
aub mutants display precocious Osk accumulation in very early stage (3/4) oocytes, 
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without dramatically affecting the level of osk mRNA. These mutants are also defective 
in polarization of the microtubule cytoskeleton and posterior localization of osk mRNA. 
Although proteins encoded by these 4 genes are components of the RNAi pathway, there 
is no evidence that they act on osk through the RNAi pathway. Nevertheless, it reveals a 
possibility that small RNAs can act as key regulators of osk translation during early 
oogenesis prior to Bru/Cup mediated repression. Consistent with this, osk mRNA in the 
ovary has been found to be associated with polyribosomes, even in the absence of 
localization of the mRNA or accumulation of Osk protein (Braat et al., 2004). 
Polyribosome association is the hallmark of mRNAs under miRNA control (Olsen and 
Ambros, 1999) and is another indication that small RNAs may be involved in osk 
translational control. 
The last protein involved in osk repression that I need to introduce is Hrp48. 
Hrp48 is a protein that binds to the same regions in the osk mRNA 3’UTR as Bru does, 
but does not appear to directly interact with Bru. Hrp48 was identified as an abundant 
Drosophila heterogeneous nuclear RNA-associated protein. It contains two N terminal 
RNA binding domains (RBDs) and a C terminal Glycine rich domain (Matunis et al., 
1992a; Matunis et al., 1992b). Several missense alleles of hrp48 display a defect in osk 
RNA localization (without affecting the microtubule cytoskeleton) where the RNA is 
dispersed in the oocyte rather than localized to the posterior pole (Huynh et al., 2004). A 
transposon insertion mutant that reduces Hrp48 levels, but does not affect the structure of 
the protein, causes derepression of a reporter mRNA with all osk regulatory sequences. 
These is also genetic evidence suggesting that reduction of Hrp48 activity affects osk 
mRNA translation, but this may or may not involve binding of Hrp48 to the osk mRNA 
(Yano et al., 2004). Biochemical analysis showed that Hrp48 binds to the AB region in 
the osk 3’UTR in a UV crosslinking assay (Gunkel et al., 1998). The binding site for 
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Hrp48 is not well defined, although a shorter AB region containing only the central 
portion of AB (removes one BRE) reduces Hrp48 binding (Gunkel et al., 1998). 
Orb is required for osk translation 
Translational repression of osk has to be overcome after localization of the mRNA 
to allow the Osk protein to accumulate at the posterior. Little is known about how this is 
achieved except that two phases are likely to be involved in the transition: derepression 
and translational enhancement. One protein that is required for osk translational 
enhancement in the oocyte is Orb (Castagnetti and Ephrussi, 2003; Chang et al., 1999; 
Christerson and McKearin, 1994; Lantz et al., 1994). Orb is the Drosophila cytoplasmic 
polyadenylation element binding (CPEB) homolog (Lantz et al., 1992). CPEB proteins 
bind to the cytoplasmic polyadenylation element (CPE) of translationally repressed 
mRNAs and facilitate their polyadenylation and expression (Mendez and Richter, 2001). 
There is an U-rich element which resembles an CPE in the osk 3’UTR, but direct 
evidence of Orb binding to the U-rich element is still lacking.  
Poly(A) tail elongation of a silenced mRNA can trigger translational initiation and 
maintaining a long poly(A) tail can be beneficial for persistent expression (Mendez and 
Richter, 2001; Paris and Richter, 1990). Three mRNAs that are involved in anterior, 
dorsal-ventral and terminal specification, bicoid, toll and torso, respectively, increase 
their poly(A) tail length concomitant with translation (Sallés et al., 1994). osk mRNA in 
wild type ovaries already has a long poly(A) tail, suggesting that the bulk part of the 
message is constitutively polyadenylated. Therefore, maintaining the poly(A) tail of osk 
mRNA at the posterior may be critical for Osk accumulation. In both strong and weak 
orb mutants, the osk mRNA poly(A) tail appears to be shorter, suggesting Orb is required 
for polyadenylation of the osk mRNA (Chang et al., 1999). Strong orb mutants arrest 
oogenesis early, preventing examination of the Osk protein level. One weak orb mutant, 
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orbMEL, allows oogenesis to complete, but little or no Osk protein is detected at the 
posterior of the oocyte, indicating Orb is also required for osk translation (Chang et al., 
1999). Therefore, Orb appears to act as a positive regulator of osk translation, and it may 
do so by polyadenylation of the osk mRNA.  
It is important to point out that positive regulation by Orb is unlikely to be the 
decisive event in translational activation of osk at the posterior pole. It has been shown 
that a long poly(A) tail is not sufficient to overcome Bru-mediated repression in osk 
3’UTR (Castagnetti and Ephrussi, 2003). Therefore polyadenylation cannot be the sole 
mechanism for derepression of osk translation at the posterior of the oocyte. Instead, 
polyadenylation is more likely to be required for enhancing osk translation after the 
translation is initiated (by a yet unknown mechanism); and allowing accumulation of Osk 
protein to levels sufficient to promote posterior patterning and germline formation 
(Castagnetti and Ephrussi, 2003). Furthermore, Orb and Bru have been shown to interact 
with each other in an immunoprecipitation experiment (Castagnetti and Ephrussi, 2003). 
It is not clear if the Bru:Orb interaction is RNA dependent, but the fact Bru and Orb 
interact suggests that both of them can be in the same RNP complex with osk mRNA 
(Chang et al., 1999). In addition, Bru binds to a cluster of BREs (the C region) in the osk 
3’UTR that is close to the polyadenylation site (Kim-Ha et al., 1995). Although the 
significance of Bru:Orb interaction is unknown, one possibility is that Bru recruits Orb to 
the osk 3’UTR, then Orb polyadenylates osk mRNA. Since Bru and Orb act on opposite 
directions on osk translation, further studies on Bru:Orb interaction may help us 
understand how the negative and positive regulatory mechanisms are coordinated on the 
osk mRNA. 
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INSIGHTS FROM BRU HOMOLOGS 
It is sometimes possible to gain insights into the function of a protein by looking 
at homologous proteins from other species, especially those that are well studied and 
have a clear function. Bru protein contains three RNA Recognition Motifs (RRMs). 
RRM1 and 2 are next to each other in the center of the protein while RRM3 is at the C-
terminus. Many proteins have a similar organization of RRMs (Ladd and Cooper, 2004; 
Paillard et al., 1998; Timchenko et al., 1996). The RRMs are highly conserved, but the 
rest of the residuals in Bru homologs are largely divergent. Two proteins are particularly 
interesting: one provides insight on the target sequence Bru may bind to; and the other 
provides a clue on which part of the Bru protein may mediate its function. 
EDEN-BP (embryo deadenylation element (EDEN)-binding protein) binds 
specifically to the EDEN motif in the 3’UTR of maternal mRNAs and targets these 
mRNAs for deadenylation and translational repression in Xenopus embryos (Paillard et 
al., 1998). EDEN-BP contains three RRMs and is closely related to Bru (Paillard et al., 
1998; Webster et al., 1997). EDEN-BP binds to sequences containing multiple U(G/A) 
repeats or UGUA/UAUG tetra-nucleotides (Audic et al., 1998). Interestingly, a BRE, 
U(G/A)U(A/G)U(G/A)U (Kim-Ha et al., 1995), can be separated into two tetra-
nucleotide elements. Given that an RRM contacts 2-4 nucleotides (Maris et al., 2005), it 
is conceivable that Bru can bind to two tetra-nucleotide elements in one BRE. This 
provides us with a new opportunity to re-examine Bru binding sites in the osk mRNA 
3’UTR when we study how Bru function. 
Another protein, Embryonic lethal abnormal vision (ELAV) type RNA binding 
protein 3 (ETR-3), provides an interesting clue about the function of the divergent region 
between RRM1/2 and RRM3. ETR-3 is a protein that also resembles the Bru protein 
domain structure. The region between RRM1/2 and RRM3 has recently been shown to be 
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important as the sequence within this region is involved in mediating the cytoplasmic 
localization of ETR-3 and splicing activity of the protein (Ladd and Cooper, 2004). This 
finding from ETR-3 presents a possibility that the same region in other proteins with 
similar domain structure are also required for their activities even though sequences in 
this region are not conserved. More details emerged from a subsequent study that 
systematically deleted short segments of this divergent region. They found that distinct 
residues within the divergent region are required for both activation and repression of 
different exons, and residues required for the repressive activity completely overlap with 
those required for activation (Han and Cooper, 2005). Although splicing and translational 
control are two very different processes, the function of the divergent region in ETR-3 
certainly provides a clue for us to start looking at Bru function, especially when we know 
that the RRMs are required for Bru binding to the osk mRNA, but the function of other 
regions including the divergent region are completely unknown. 
OVERVIEW OF THE DISSERTATION RESEARCH 
There are two major aims of the research in this thesis, to identify additional 
targets of Bru and factors that may act upstream/downstream of Bru in the same pathway, 
and to understand the molecular mechanism of how Bru regulates osk translation. 
To identify additional targets of Bru and/or other genes that act in the same 
pathway, I performed a genetic screen looking for dominant modifiers of the aret mutant 
phenotype (aret is the gene that encodes Bru) (Schüpbach and Wieschaus, 1991; Webster 
et al., 1997). Two of the modifiers suggested additional targets for Bru action. One 
modifier is Star, a gene that contributes to provision of Gurken activity (Gurken specifies 
the dorsal-ventral axis) (Ghiglione et al., 2002). Females heterozygous for Star- and 
homozygous for aret- produce excess Gurken protein, supporting the proposal by the 
Ephrussi lab that gurken is an additional target of Bru (Filardo and Ephrussi, 2003). The 
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second suggested target is a gene acting in the Delta signaling pathway. Females 
heterozygous for Delta- and homozygous for aret- display a phenotype very similar to 
that of homozygous Delta mutants (Lopez-Schier and St Johnston, 2001), and aret 
mutants have significantly reduced level of Delta protein at the interface of germline and 
follicle cells. A final modifier, Lk6, may prove to be informative about the mechanism of 
Bru-dependent translational repression. Lk6 encodes a protein kinase predicted to 
regulate the rate-limiting initiation factor eIF4E (Lachance et al., 2002). 
I also took a more biochemical approach in a quest of the mechanism by which 
Bru regulates osk translation. Bru protein contains three RRMs, but the remainder of the 
protein had no known function. I identified a domain (which we now call the interaction 
domain), that is required for interaction to three other protein tested – Bru itself (a novel 
finding of this study), Cup (Nakamura et al., 2004) and Apontic (Lie and Macdonald, 
1999b). Subsequent analysis, including in vivo experiments, of mutant forms of Bru 
defective in these interactions led us to an unexpected discovery of a novel role of Bru 
protein – it also acts as an activator of osk translation. Parallel analysis of Bru binding 
sites in the osk mRNA 3’UTR fully supports the notion that Bru has a dual role. There are 
two clusters of BREs in osk mRNA 3’UTR (Kim-Ha et al., 1995). Point mutations in one 
cluster (close to 5’ end of the 3’UTR) cause overproduction of Osk protein while point 
mutations in the other cluster (close to the polyadenylation site) largely prevent 
translation of the message. 
In order to understand the molecular basis of the opposing roles of Bru, I used 
quantitative methods to better define and compare the binding of Bru to the different 
regulatory elements: those that either repress or activate osk mRNA translation. Using 
purified components I found that Bru binds to two clusters of binding sites in the osk 
3’UTR differently, in terms of affinity, cooperativity and apparent compaction of the 
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RNA. This work raises the possibility that the details of how Bru binds its substrate may 
determine whether it acts as a repressor or an activator. 
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arrest mutants have pleiotropic phenotypes, ranging from an early arrest of 
oogenesis to irregular embryonic segmentation defects. One function of arrest is in 
translational repression of oskar mRNA; this biochemical activity is presumed to be 
involved in other functions of aret. To identify genes that could provide insight into how 
arrest contributes to translational repression, or that may be targets for arrest-dependent 
translational control, we screened deficiency mutants for dominant modification of the 
arrest phenotype. Only four of the many deficiencies tested, which cover ~30% of the 
genome, modified the starting phenotype.  One enhancer, identified fortuitously, is the 
Star gene. Star interaction with arrest results in excess Gurken protein, supporting the 
model that gurken is a target of repression. Two modifiers were mapped to individual 
genes. One is Lk6, which encodes a protein kinase predicted to regulate the rate-limiting 
initiation factor eIF4E. The second is Delta. The interaction between arrest and Delta 
mimics the phenotype of homozygous Delta mutants, suggesting that arrest could 
positively control Delta activity. Indeed, arrest mutants have significantly reduced levels 




Translational control has long been recognized as an important regulatory process 
in the early stages of animal development.  Classical studies focused on the dramatic 
change in translation activity that occurred after fertilization in amphibians (Davidson, 
1986).  More recent discoveries revealed transcript-specific forms of regulation, such as 
the coordinated activation of large classes of mRNAs by interaction of CPE binding 
protein with the Cytoplasmic Polyadenylation Element (CPE) and subsequent extension 
of the poly(A) tail (Mendez and Richter, 2001). Control events that may be specific for 
small numbers of mRNAs have emerged from the analysis of body patterning in 
Drosophila, where the transcripts encoding determinants that define the dorsoventral and 
anteroposterior axes of the egg are subject to elaborate programs of localization and 
translational regulation (Lipshitz and Smibert, 2000).  For the bicoid mRNA, which 
encodes the anterior determinant, translation appears to be activated as a consequence of 
poly(A) tail extension shortly after fertilization (Sallés et al., 1994). The oskar (osk) and 
gurken (grk) mRNAs, which encode proteins whose positions specify posterior and 
dorsal fates, respectively, are under more complex forms of control.  Transcription of osk 
mRNA begins very early in oogenesis, but Osk protein does not appear at high levels 
until mid oogenesis when the osk mRNA becomes localized to the posterior pole of the 
oocyte (Kim-Ha et al., 1995; Markussen et al., 1995; Rongo et al., 1995). The 
translational repression of osk mRNA prior to its localization is achieved in part through 
the action of Bruno (Bru), a protein that binds to regulatory sequences, BREs, in the osk 
3’ UTR (Kim-Ha et al., 1995; Webster et al., 1997). Bru also appears to regulate the grk 
mRNA, as Bru can bind to grk mRNA and overexpression of a bru cDNA leads to 
dorsoventral patterning defects consistent with a reduction in Grk activity (Filardo and 
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Ephrussi, 2003; Kim-Ha et al., 1995; Norvell et al., 1999). At present the mechanism by 
which Bru represses translation is only poorly understood.  
Bru is encoded by the arrest (aret) gene (Schüpbach and Wieschaus, 1991; 
Webster et al., 1997). Bru protein was characterized and named before the discovery that 
it corresponds to aret, and is widely known by the name Bru. In this paper we refer to the 
gene and mutants as aret, and the gene products as Bru.  The phenotype of aret mutants 
suggests that Bru is likely to regulate other mRNAs in addition to the known targets, 
since some aspects of the phenotype are not readily attributed to misregulation of either 
osk or grk. During wild type oogenesis cysts of 16 germline cells, which remain 
interconnected because of incomplete cytokinesis, are formed in the germarium. 
Individual cysts bud off and become enveloped by a layer of somatic follicle cells to 
create an egg chamber. One germline cell in each cyst becomes specified as the oocyte, 
while the remaining 15 become nurse cells (Spradling, 1993). In strong aret mutants, 
such as aretQB, the cysts contain variable numbers of germline cells that complete 
cytokinesis and fail to differentiate and specify an oocyte (Parisi et al., 2001; Schüpbach 
and Wieschaus, 1991). Overexpression of osk or grk mutants does not cause such a 
phenotype (Ghiglione et al., 2002; Neuman-Silberberg and Schupbach, 1994; Smith et 
al., 1992), suggesting that aret regulates expression of one or more other mRNAs.  
Some alleles of aret have weaker phenotypes that also reveal the pleiotropic 
character of the gene (Schüpbach and Wieschaus, 1991; Webster et al., 1997). In 
intermediate allelic combinations, such as aretQB/aretPD or aretQB/aretPA, 
morphologically normal egg chambers form and an oocyte is specified, but after stage 6 
or 7 the egg chambers become necrotic. Again, overexpression of either osk or grk does 
not lead to this phenotype. Females of the weakest allelic combinations, such as 
aretPD/aretPA, produce eggs that can be fertilized and develop to a late stage of 
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embryogenesis. Many of the embryos have irregular anteroposterior patterning defects 
revealed by alterations of the ventral denticle belts: some individual segments are missing 
or adjacent segments are partially fused. Although overexpression of osk or grk does 
cause embryonic patterning defects, these defects are very specific and consistent, and are 
unlike those of the aret mutants.  
One genetic approach that could be useful in learning more about the function of 
Bru is an interaction screen, in which mutants are tested for their ability to modify aret- 
phenotypes. This approach has been used with considerable success to identify loss-of-
function mutants that dominantly modify an existing phenotype (Simon et al., 1991). An 
interaction screen offers the possibility of providing insights into two of the main 
questions about the function of Bru. How does Bru repress translation? And what 
additional mRNAs are regulated by Bru?  A reduction in the dosage of a gene that acts in 
the same process as Bru could enhance or suppress the aret phenotype. Similarly, a 
reduction in the level of an mRNA normally repressed by Bru could suppress the aret 




To identify genes that interact with aret we tested third chromosome deficiency 
mutants for the ability to dominantly suppress the ovarian aret phenotype. The mutants 
are from the 'deficiency kit' maintained by the Bloomington Stock Center, and the subset 
that could be used (those not requiring the presence of a duplication) cover about 74% of 
the chromosome.  To streamline the crossing scheme the aretPD chromosome was 
marked with the dominant eye marker, S1, such that flies of the desired genotype could 
be identified despite the absence of second chromosome markers or balancer 
chromosomes in the deficiency stocks (see Fig. 2.1). Serendipitously, the S1 mutation 
proved to dominantly enhance the aret phenotype, thus identifying an initial modifier 
mutant.  
For each genotype the ovaries from multiple females were dissected and fixed, 
stained with DAPI to highlight nuclei, and examined by fluorescence microscopy. Wild 
type or aretPD heterozygous females have ovaries with all stages of oogenesis 
represented (Fig. 2.2A). In contrast, oogenesis in S1 aretPD/Df(2L)esc-P2-0 females is 
arrested at the germarial stage (Fig. 2.2B).  The vast majority of the deficiency mutants 
have no consistent effect on the S1 aretPD/Df(2L)esc-P2-0 oogenesis phenotype (Fig. 
2.2C; Table 1), thus the starting phenotype is not overly sensitive to variations in genetic 
background. Only four deficiencies elicited a clear dominant alteration of the starting 
phenotype, either delaying the arrest (Fig. 2.2E) or increasing the number of germ cells in 
undifferentiated germaria (Fig. 2.2D). These, as well as S1, were examined in detail. Not 
surprisingly, in no case was suppression of the aret phenotype complete. Instead, the 
arrest of oogenesis was extended to a later stage of development, but not to the point of 
egg laying. 
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Star1 interacts with aret 
Ovaries of aretPD/Df(2L)esc-P2-0 females have an intermediate aret phenotype, 
in which oogenesis proceeds as far as stage 7 before the egg chambers degenerate (Fig. 
2.3A). When S1 is also present, in S1 aretPD/Df(2L)esc-P2-0 ovaries, the arrest of 
oogenesis is advanced to the germarial stage (Fig. 2.3B). S1 has no dominant ovarian 
phenotype by itself (data not shown), and is thus acting as a dominant enhancer of the 
starting phenotype.  This genetic interaction could be between S and aret, which is 
homozygous mutant in the affected flies, or between S and any of the genes made 
hemizygous by Df(2L)esc-P2-0. To distinguish between these possibilities we asked if S1 
enhances the phenotype of flies in which only aret is mutant. The aretPD/aretPA allelic 
combination has a weak phenotype (Fig. 2.3C), with many egg chambers producing 
mature oocytes that can be fertilized and progress through much of embryogenesis. When 
S1 is also present, the phenotype becomes more severe and oogenesis arrests at stage 6 or 
7 (Fig. 2.3D). The phenotype of aretPD/aretQB, in which an oocyte is specified but 
oogenesis arrests at stage 6/7 (Fig. 2.3E), is similarly enhanced by S1.  The arrest occurs 
earlier, at about stage 3 (Fig. 2.3F), and no oocyte is specified (data not shown).  We 
conclude that S1 is interacting with aret. This interaction does not appear to reflect Bru-
dependent regulation of S mRNA translation, as no changes in S protein levels were 
detected (data not shown). The aret/S1 interaction is persistent during oogenesis, 
occurring at different stages.  Thus either aret and S interact in an ongoing process, or the 
severity of the defect in some initial process influences later events.  
A genetic interaction between S and aret is not surprising, since both have been 
implicated in expression or activity of grk. Grk is a transforming growth factor (TGF) 
alpha-like protein that is expressed as a membrane-bound form in the germline (Neuman-
Silberberg and Schüpbach, 1993; Neuman-Silberberg and Schüpbach, 1996; Serano et al., 
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1995). After proteolytic cleavage separates intra- and extracellular domains, the latter 
activates epidermal growth factor receptor (Egfr) in the overlying follicle cells (Ghiglione 
et al., 2002; Ray and Schupbach, 1996). S is required for the activity of Grk and appears 
to act in post-cleavage trafficking or secretion of the protein (Ghiglione et al., 2002). 
Overexpression of Bru reduces the level of grk activity and the amount of localized Grk 
protein (Filardo and Ephrussi, 2003).  Thus the combined effects of reduction of both aret 
and S activity could well affect the level of grk activity. To determine if the amount or 
distribution of Grk protein is altered in S1 aretPD/aretPA ovaries, we monitored the 
protein in whole mount preparations by immunofluorescence. In wild type ovaries Grk 
protein accumulates in the oocyte during early stages (Fig. 2.4A), and then becomes 
restricted to an anterodorsal region over the oocyte nucleus in stages 8-10. A similar Grk 
accumulation is observed in aret mutant ovaries (Fig. 2.4B). When the S1 mutation is 
also present, in S1 aretPD/aretPA ovaries, Grk protein can now be detected at low levels 
in nurse cells (Fig. 2.4C).  In some preparations this nurse cell staining is concentrated at 
cell boundaries (Fig. 2.4D), as if the protein is membrane-associated. 
Lk6, which encodes a protein kinase predicted to phosphorylate eIF4E, interacts 
with aret 
Df(3R)M-Kx1, which removes parts of cytological intervals 86 and 87, 
dominantly suppresses the S1 aretPD/Df(2L)esc-P2-0 phenotype (Fig. 2.2E). The 
interaction is with aret, rather than S or Df(2L)esc-P2-0, since Df(3R)M-Kx1 also 
suppresses aretPD/aretQB (Fig. 2.5A and B) and aretPA/aretQB (data not shown).  The 
interacting gene was identified by testing smaller deficiencies and P element insertion 
mutants for the interaction (Fig. 2.5C and data not shown). The P element mutant 
EP(3)0886, which is inserted 5' to the Lk6 gene (Huang and Rubin, 2000; Kidd and Raff, 
1997), suppresses the phenotype of aretPD/aretQB (Fig. 2.5C) and of aretPD/Df(2L)esc-
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P2-0 (data not shown). EP P elements, such as EP(3)0886, contain a GAL4-inducible 
promoter that, in conjunction with a source of GAL4, directs expression of the 
endogenous gene located proximal to the P element (Rorth et al., 1998), in this case Lk6.  
The suppression of the aret phenotype occurs in the absence of GAL4, consistent with 
the notion that the EP insertion by itself reduces Lk6 expression. When a germline source 
of GAL4 is provided, EP(3)0886 enhances the aretPD/aretQB phenotype (Fig. 2.5D). 
The complementary suppression and enhancement from the same P element demonstrates 
that Lk6 interacts with aret. This interaction could reflect Bru-dependent control of Lk6 
mRNA translation. This interpretation is unlikely, as Lk6 protein levels appear similar in 
wild type and aret mutants (data not shown). 
The effect of the Lk6 mutation on the aret oogenesis arrest phenotype persists 
throughout oogenesis, as different aret allelic combinations that arrest oogenesis at 
different stages all show suppression. The early arrest of aretQB/aretQB at stage 2 is 
extended to stage 3 or 4 when EP(3)0886 is present, and the stage 6/7 arrest of 
aretPD/aretQB is extended to stage 9.  Furthermore, the low hatch rate of embryos from 
aretPA/aretPD mothers (3% n=300) is elevated (14% n=300) when the mothers also 
carry one copy of EP(3)0886.  The suppression of aret mutants by reduction of Lk6 is 
paralleled by enhancement of the phenotype when Lk6 is overexpressed. In the 
aretPD/aretQB combination the arrest was shifted from stage 6/7 to stage 3, and with the 
aretPA/aretPD combination, which normally allows the completion of oogenesis, 
oogenesis was arrested at stage 9/10. 
In addition to the oogenesis arrest phenotype, strong aret mutants can have cysts 
with greater than 16 germline cells (Parisi et al., 2001; Schüpbach and Wieschaus, 1991). 
This aspect of aret function does not appear to interact with Lk6:  neither the deficiency 
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that removes Lk6, Df(3R)M-Kx1, nor EP(3)0886 suppresses the extra germline cells 
phenotype (data not shown).   
The Lk6 protein is predicted to phosphorylate and thus enhance activity of 
translation initiation factor eIF4E (Lachance et al., 2002), and could act through that 
pathway in suppressing the aret phenotype. Specifically, a global reduction in translation 
efficiency from reduced eIF4E activity could offset the enhanced translation of an mRNA 
negatively regulated by aret. To evaluate this possibility we asked if expression of a 
constitutively activated eIF4E, eIF4E S251D, in which the serine predicted to be 
phosphorylated by Lk6 is mutated to a negatively charged amino acid (Lachance et al., 
2002), would reverse the suppression caused by the Lk6 mutant.  Females of the genotype 
aretQB/aretPD; EP(3)0886/+ show the same timing of arrest - at stage 9 - as females of 
the genotype aretQB/aretPD P[eIF4E S251D]; EP(3)0886/+. This result suggests that 
expression of the constitutively activated eIF4E has no effect on the suppression of the 
aret phenotype by the Lk6 mutant. However, the P[eIF4E S251D] transgene can itself 
suppress the aretQB/aretPD phenotype, and delay arrest until stage 9. Thus either 
enhanced activity of eIF4E, provided by the P[eIF4E S251D] transgene, or a predicted 
reduction of eIF4E activity, from the Lk6 mutant, has the same effect on the aret 
phenotype, and interpretation of the suppression observed in the aretQB/aretPD P[eIF4E 
S251D]; EP(3)0886/+ females is not simple.  
Additional Dfs dominantly suppress the timing of oogenesis arrest 
Only two other third chromosome deficiency mutants suppressed the timing of 
oogenesis arrest of S1 aretPD/Df(2L)esc-P2-0 females. One of these, Df(3R)mbc-R1, also 
suppressed the arrest phenotype of aretQB/aretQB, showing that it is acting on aret. Just 
as for Lk6-mediated suppression, there was no effect on the occurrence of cysts with 
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greater than 16 germline cells.  We have not been able to identify a point mutant from 
within the region uncovered by this deficiency that displays a similar interaction. 
The other suppressing deficiency, Df(3R)vin5, subsequently failed to suppress 
either aretQB homozygotes or aretPA/aretQB females. This deficiency presumably 
interacts with S1, with Df(2L)esc-P2-0, or with a combination of the mutations on the 
input chromosomes, and was not characterized further. 
Delta and aret interact 
Females of genotype S1 aretPD/Df(2L)esc-P2-0; Df(3R)Dl-BX12/+ have ovaries 
in which no cysts with the usual 16 germ cells form. Instead, in each ovariole a single 
layer of follicle cells surround a large number of undifferentiated germ cells (Fig. 2.2D). 
The interacting genes responsible for the phenotype are Delta (Dl) and aret ; females 
homozygous or transheterozygous for aret alleles and heterozygous for Dl9P, an 
amorphic allele, show a similar phenotype.  Females homozygous for the strong aretQB 
allele, in which cysts form but no oocyte is specified, and heterozygous for Dl9P, have an 
ovarian phenotype similar to that observed with Df(3R)Dl-BX12 in the screen (Fig. 2.6). 
In aretQB/aretQB ovaries, no oocyte is specified (Fig. 2.6A) and individual cysts 
sometimes have greater than 16 germline cells (Fig. 2.6A'). When also heterozygous for 
Dl9P, almost all ovarioles now consist of the germarium and a single large egg chamber 
with many germline cells (the egg chamber is small in rare exceptions). This egg 
chamber could arise from fusion of initially separate egg chambers, or from 
overproliferation of the germ line. It is often possible to distinguish between these 
options, since the cell divisions that produce the germline cells have incomplete 
cytokinesis.  Consequently, each daughter cell remains connected to its parent by a ring 
canal, and a branched organelle, the fusome, extends through the ring canals (Fig. 2.6C). 
The number of cell divisions within a cyst can be determined by counting the number of 
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ring canals of the oocyte. However, in the strong aret mutants cytokinesis is complete, 
there are no ring canals, and the fusome appears as dots (Fig. 2.6D). In the single large 
egg chamber of aretQB/aretQB; Dl9P/+ ovarioles, the fusome also appears as dots (Fig. 
2.6E), and so we unable to determine how these egg chambers form. The Dl mutation 
could be enhancing the frequency and severity of the germline overproliferation 
phenotype of aretQB. Alternatively, the aret mutations could be enhancing the egg 
chamber fusion phenotype of Dl mutants (Lopez-Schier and St Johnston, 2001).     
A weaker combination of aret alleles also interacts with Dl9P. In aretPD/aretQB 
ovaries, oogenesis proceeds as far as stage 6/7 (Fig. 2.7D).  In aretPD/aretQB; Dl9P/+ 
ovaries most egg chambers have greater than 16 germline cells (Fig. 2.7A-C), a situation 
that can again occur by overproliferation within a single egg chamber or fusion of 
multiple egg chambers. This genotype produces three classes of abnormal egg chambers, 
which are present in roughly equal numbers. In one class, a large number of germline 
cells of roughly equal size are enveloped by a single epithelium of follicle cells (Fig. 
2.7A). This phenotype is similar to that seen when using the stronger aret alleles, 
including the absence of an oocyte. The remaining two classes clearly arise from fusion. 
They both display partial fusion, with individual cysts failing to separate from one 
another, though they differ in the nature of the fusions. 
In wild type and aretPD/aretQB ovaries adjacent egg chambers are connected by 
several stalk cells positioned between the anterior polar cell of one egg chamber and the 
posterior polar cell of the next (Fig. 2.7D and E). For the partially fused egg chambers of 
aretPD/aretQB; Dl9P/+ flies, no stalk cells can be detected and the follicle cell layers of 
different egg chambers remain in intimate contact with one another (Fig. 2.7C'). Some 
maintain a well-defined linear organization within individual ovarioles, and adjacent egg 
chambers are fused with each other at their anterior and posterior boundaries (Fig. 2.7C); 
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we refer to this class as A/P fusions.  The other class of partially fused egg chambers – 
called random fusions - reside in ovarioles in which the normal beads-on-a-string 
organization is absent.  Egg chambers are positioned irregularly and can be closely 
apposed to multiple different egg chambers on lateral as well as anterior and posterior 
surfaces (Fig. 2.7B). For both classes of partial fusion each cyst has an oocyte as 
determined by the presence of a single cell with a high concentration of the oocyte 
marker Orb (data not shown), although specific Orb staining is lost at the later stages 
when the cysts begin to degenerate. In the A/P fusions the oocyte is clearly at the 
posterior of the cyst. Defining the position of the oocyte in the random fusions is 
somewhat subjective, given the absence of an tandem arrangement of cysts, but in all 
cases the oocyte is either lateral or posterior relative to the overall polarity of the ovariole 
(data not shown).   
The parital fusion phenotypes of aretPD/aretQB; Dl9P/+ are very similar to those 
of Dl/Dl germline clones (see Discussion).  A simple interpretation of this similarity is 
that Dl activity is reduced in aret mutants, through a reduction in the synthesis or 
presentation of Dl protein. To test this prediction we examined Dl protein in wild type 
and aretPD/aretQB ovaries.  Dl normally accumulates at the highest levels in the 
membranes separating the follicular epithelium from the nurse cells and oocyte, with a 
lower level of cytoplasmic staining (Fig. 2.8A). In the aret mutant the level of 
membrane-associated Dl is clearly reduced, although the cytoplasmic staining is not 
visibly different (Fig. 2.8B).  Because the role of Dl is in signaling from the germline cell 
to the follicle cells, the protein at the junction between these cells is expected to be the 
active form.  Thus aret does appear to have a positive role, probably indirect, in 
promotion of Dl activity. 
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In the third class of abnormal egg chambers a large number of germline cells of 
roughly equal size are enveloped by a single epithelium of follicle cells (Fig. 2.7A). This 
phenotype is similar to that seen when using the stronger aret alleles, including the 
absence of an oocyte. 
DISCUSSION 
We performed a screen of third chromosome deficiencies for dominant modifiers 
of aret mutants. About three quarters of the third chromosome was screened, 
corresponding to roughly 30% of the genome. Only four deficiencies dominantly 
modified the aret mutant phenotype, suggesting that the total number of genes in the 
genome with this property is small. For two of the four deficiencies we were able to 
identify the gene responsible for the interaction, and we fortuitously discovered a third 
interacting gene while preparing for the screen.  We anticipated that two different types 
of modifiers might be detected by the screen: those in genes that act in the same process 
as Bru, and those in genes that are themselves regulated by Bru, or act in a process in 
which a limiting component is regulated by Bru. Characterization of the interacting genes 
suggests that we recovered examples of each type of modifier. 
Interaction of aret and S 
Bru has been proposed to translationally regulate grk mRNA. The supporting 
evidence includes (i) binding of Bru to grk mRNA in vitro and indirect evidence of 
binding in vivo (Filardo and Ephrussi, 2003; Kim-Ha et al., 1995; Norvell et al., 1999), 
(ii) rare dorsoventral patterning defects as a consequence of overexpression of Bru, and 
enhancement of this phenotype by reduction of grk gene dosage, and (iii) evidence that 
localized Grk is present at reduced levels when Bru is overexpressed, although 
unlocalized Grk appears more abundant (Filardo and Ephrussi, 2003).  However, there 
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has been no evidence of excess Grk protein in aret mutants. S is required for grk activity, 
and it acts post-translationally in either trafficking or secretion of Grk protein (Ghiglione 
et al., 2002). We found that when flies were both homozygous for aret and heterozygous 
for S1 they accumulated Grk protein in nurse cells, while ectopic accumulation could not 
be detected in either aret mutants or S1 heterozygotes alone. This synthetic effect on Grk 
protein accumulation is simple to rationalize. In aret mutants Grk protein is excessively 
translated, but an S-dependent delivery step could efficiently clear the protein from the 
nurse cells. When S activity is reduced, a detectable level of Grk remains in the nurse 
cells. The distribution of the ectopic Grk, in both cytoplasm and at the nurse cell 
boundaries, could correspond to the sites where the protein might stall during delivery. 
The actual site of S action is not known, and two different sites of S concentration, in 
endoplasmic reticulum or on the plasma membrane, have been reported (Ghiglione et al., 
2002; Pickup and Banerjee, 1999). Although this explanation has some appeal, it is 
important to note that none of the evidence firmly establishes a role for Bru in 
translational repression of grk mRNA, and it remains possible that Bru could, for 
example, influence the site of translation rather than its efficiency.  
Although the combination of S1 and aret mutations does affect Grk expression or 
distribution, there are no precedents that clearly demonstrate how excess or ectopic Grk 
would enhance the oogenesis arrest phenotype of aret mutants. Thus the explanation for 
the enhancement remains unknown, and could involve the effects on grk or on other 
genes that are subject to regulation by Bru. 
Is there a link between Bru and initiation of translation?  
The eIF4E protein binds to the cap at the 5’ end of mRNAs. It is a rate-limiting 
component of translational initiation, and its activity is under tight control (Gingras et al., 
1999). One form of regulation is phosphorylation, which is thought to control the mRNA 
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cap-binding activity of eIF4E (Marcotrigiano et al., 1997; Raught et al., 2000). Several 
lines of correlative evidence suggest that this phosphorylation is important for cell 
proliferation (Bonneau and Sonenberg, 1987; Raught et al., 2000), and mutation of the 
Drosophila eIF4E to prevent phosphorylation results in reduced viability and poor growth 
(Lachance et al., 2002). 
A transgene expressing a mutant and constitutively activated version of eIF4E, in 
which the regulatory phosphorylation is mimicked by a amino acid change, can suppress 
the aret phenotype. This result raises the possibility that Bru has a positive role in 
initiation of translation. Specifically, in the aret mutant one or more target mRNAs that 
require Bru for activation of translation may be underexpressed, and increasing 
translation suppresses this defect. 
However,  the aret mutant phenotype is also suppressed by a mutation of Lk6, and 
enhanced by overexpression of Lk6. Lk6 is the Drosophila protein most closely related to 
mammalian mitogen-activated protein kinase-interacting protein kinase 1 (MNK1), 
which phosphorylates translation initiation factor eIF4E after activation by either the 
p44/42 or p38 MAPKs (Fukunaga and Hunter, 1997; Lachance et al., 2002; Waskiewicz 
et al., 1997). Thus mutation of Lk6 might be expected to reduce eIF4E phosphorylation 
and thereby decrease translational capacity. By this view the suppression of the aret 
phenotype would be consistent with an interaction between eIF4E and Bru that involves 
the known function of Bru in translational repression. In favor of this notion (Nakamura 
et al., 2004) have recently shown that Bru physically interacts with Cup, an eIF4E 
binding protein that is required for repression of osk mRNA translation. To explore this 
possibility further we asked if suppression of the aret phenotype by EP(3)0886 was 
accompanied by a change in the levels of Osk or Grk proteins, or if homozygous 
EP(3)0886 females have abnormal amounts of either protein. No change was seen in 
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either case (data not shown). Thus we do not know if the Lk6 mutation impacts the 
function of aret in repression of osk or grk mRNAs.  
Given the similar consequences on the aret phenotype of the constitutively active 
eIF4E and the mutant predicted to reduce eIF4E activity, the simplest explanation is that 
Lk6 may affect aret function by a means other than phosphorylation of eIF4E. 
Suppression of the aret phenotype by the mutant eIF4E clearly suggests a link between 
Bru and the initiation of translation, although this need not be direct. 
Interaction of aret and Dl 
The combination of aretPD/aretQB with Dl9P/+ produces a variety of ovarian 
defects, complicating interpretation of the phenotype. Nevertheless, one striking feature 
is the similarity of many of the defects to those seen when Dl activity is largely or 
completely eliminated, suggesting that the aret mutations are enhancing the Dl 
phenotype. Dl is a component of the Notch/Dl signaling pathway, which acts in many 
signaling events in a wide range of cell types (Artavanis-Tsakonas et al., 1999). In the 
ovary Dl is required in the germline cells for control of differentiation and proliferation of 
the somatic follicle cells, and for setting up anteroposterior polarity (Lopez-Schier and St 
Johnston, 2001; Torres et al., 2003). The earliest and, at least initially, most dramatic 
consequence of loss of Dl activity is the fusion of cysts - the phenotype most apparent in 
the aretPD/aretQB; Dl9P/+ ovaries. 
Large germ line clones of strong Dl mutant alleles cause a complete fusion of egg 
chambers into a single egg chamber with multiple cysts, reminiscent of the complete 
fusions described here. Smaller clones retain a more regular ovariole organization. 
Individual egg chambers with Dl germ line clones often fuse with the adjacent anterior 
wild type egg chamber. Fusion can be incomplete, resulting in a double layer of follicle 
cells that separate the egg chambers, much as observed for the A/P partial fusions we 
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report. However, the similarities are not perfect. For example, Dl mutant clones 
upregulate FasIII in the follicular epithelium (Lopez-Schier and St Johnston, 2001), but 
aretPD/aretQB; Dl9P/+ egg chambers do not (data not shown). Other features of the Dl 
mutant phenotype, such as the defects in anteroposterior polarity (Torres et al., 2003), are 
difficult to detect in the aretPD/aretQB; Dl9P/+ ovaries, because of their arrest of 
oogenesis. The lack of perfect correspondence between the Dl germ line clones and the 
aretPD/aretQB; Dl9P/+ ovaries is not surprising for several reasons. First, there is 
substantial phenotypic variation even among the Dl germ line clones, if both large and 
small clones are considered.  Second, the clones are homozygous for Dl-, while in the 
aret mutant background one wild type copy of Dl remains. Third, the Dl-like defects in 
aretPD/aretQB; Dl9P/+ ovaries are superimposed on the aret mutant phenotype.  
The simplest interpretation of our results is that the aret mutations are reducing 
the activity of the N/Dl signaling pathway, which in combination with mutation of one 
copy of Dl leads to phenotypes similar to those resulting from loss of Dl. This model is 
fully supported by the finding that in aret mutants the amount of Dl protein concentrated 
at the border between germline cells and follicle cells is reduced. What remains unclear is 
how this reduction occurs. Assuming that Bru is acting as a translational repressor, in the 
aret mutant the target protein should be present at elevated levels.  By this model the 
target should be a gene that normally has a negative effect on Dl expression or delivery to 
the membrane.  Alternatively, Bru could also have a role in translational activation, in 
which case Dl could be a direct target. This seems quite unlikely, as the Dl 3' UTR lacks 
any recognizable BREs, the sequences to which Bru is known to bind. Nevertheless, a 
role for Bru in translational activation is possible, and the target could normally have a 
positive effect on provision of Dl activity. 
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MATERIALS AND METHODS 
Fly stocks:  aret mutants (Schüpbach and Wieschaus, 1991) were from Trudi 
Schupbach. Deficiency mutants, P element insertion mutants, and the Star1 (S1) allele 
were obtained from the Bloomington Stock Center. P[eIF4E S251D] was from Paul 
Lasko. nosGAL4VP16 (Van Doren et al., 1998) was from Ruth Lehmann. mat 4-GAL4-
VP16#6 was obtained by jumping the P element in mat 4-GAL4-VP16 V32a (Martin and 
St Johnston, 2003), obtained from Daniel St Johnston. The S1 aretPD and aretPD 
P[eIF4E S251D]  chromosomes were constructed by recombination using standard 
genetic methods. 
Deficiency screen: The cross scheme shown in Fig. 2.1 was used to generate 
adults of the desired genotypes. After 3-4 days in well-yeasted vials, females were 
dissected and the ovaries fixed in 4% formaldehyde in PBS for 20-30 minutes. After 
rinsing several times in PBT (PBS plus 0.1% Triton X-100), the ovaries were mounted in 
Vectastain (Vector Labs) containing DAPI to label nuclei.  Ovaries were examined using 
a Nikon epifluoresence microscope.  
Antibody staining: Ovaries were fixed as described above, blocked in PBT plus 
5% goat serum, and incubated overnight in PBT plus 1% goat serum and the primary 
antibody. After several washes in PBT plus 1% goat serum, secondary antibodies were 
added for 2 hours, followed by several washes in PBT. In some cases DNA was 
counterstained with ToPro-3 (Molecular Probes) diluted 1/1000. Samples were mounted 
in Vectastain and imaged by confocal microscopy with a Lecia TCS-SP.  Primary 
antibodies, all from Developmental Studies Hybridoma Bank unless otherwise noted, 
were used at the following dilutions: mouse anti-Grk, 1/10; rat anti-Star (Uptal Banerjee), 
1/10; mouse anti-Orb, 1/20; mouse anti-Hts 1B1, 1/10; mouse anti-FasIII, 1/10; rabbit 
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TABLE 
Table 1. Deficiencies used in the screen. 
Genotype  Breakpoints Modification 
Df(3L)emc-E12 061A;061D03  
Df(3L)Ar14-8 061C05-08;062A08  
Df(3L)Aprt-32 062B01;062E03  
Df(3L)R-G7 062B08-09;062F02-05  
Df(3L)M21 062F;063D  
Df(3L)HR119 063C02;063F07  
Df(3L)GN34 063E06-09;064A08-09  
Df(3L)GN24 063F06-07;064C13-15  
Df(3L)ZN47 064C;065C  
Df(3L)XDI98 065A02;065E01  
Df(3L)BSC27 065D04-05;065E04-06  
Df(3L)pbl-X1 065F03;066B10  
Df(3L)BSC13 066B12-C01;066D02-04  
Df(3L)h-i22 066D10-11;066E01-02  
Df(3L)Scf-R6 066E01-06;066F01-06  
Df(3L)29A6 066F05;067B01  
Df(3L)AC1 067A02;067D07-13 or 067A05;067D09-13 
Df(3L)BSC14 067E03-07;068A02-06  
Df(3L)lxd6 067E05-07;068B02-04  
Df(3L)vin2  067F02-03;068D06   
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Df(3L)vin5 068A02-03;069A01-03 + 
Df(3L)iro-2 069B01-05;069D01-06  
Df(3L)E44 069D02;069E03-05  
In(3LR)C190[L] 069F03-04;070C03-04  
Df(3L)fz-GF3b 070C01-02;070D04-05  
Df(3L)fz-M21 070D02-03;071E04-05  
Df(3L)BK10 071C;071F  
Df(3L)brm11 071F01-04;072D01-10  
Df(3L)st-f13 072C01-D01;073A03-04  
Df(3L)81k19 073A03;074F  
Df(3L)W10 075A06-07;075C01-02  
Df(3L)Cat 075B08;075F01  
Df(3L)XS2182 076B;076F  
Df(3L)XS543 076B;077A  
Df(3L)kto2 076B01-02;076D05  
Df(3L)XS533 076B04;077B  
Df(3L)XS572 076B06;077C01  
Df(3L)rdgC-co2 077A01;077D01  
Df(3L)ri-79c 077B-C;077F-78A  
Df(3L)ME107 077F03;078C08-09  
Df(3L)31A 078A;078E, 078D;079B  
Df(3L)Pc-2q 078C05-06;078E03-079A01  
Df(3L)Ten-m-AL29 079C01-03;079E03-08  
Df(3L)HD1 079D03-E01;079F03-06  
Df(3L)Delta1AK 079E05-F01;079F02-06  
 48 
Df(3R)ME15 081F03-06;082F05-07  
Df(3R)3-4 082F03-04;082F10-11  
Df(3R)e1025-14 082F08-10;083A01-03  
Df(3R)Scr 084A01-02;084B01-02  
Df(3R)Antp17 084B01-02;084D11-12 or A06,D14  
Df(3R)p712 084D04-06;085B06  
Df(3R)p-XT103 085A02;085C01-02  
Df(3R)BSC24 085C04-09;085D12-14  
Df(3R)by10 085D08-12;085E07-F01  
Df(3R)by62 085D11-14;085F06  
Df(3R)M-Kx1 086C01;087B01-05 + 
Df(3R)ry615 087B11-13;087E08-11  
Df(3R)ea 088E07-13;089A01  
Df(3R)sbd105 088F09-89A01;089B09-10  
Df(3R)P115 089B07-08;089E07-08;020  
Df(3R)DG2 089E01-F04;091B01- B02  
Df(3R)C4 089E03-04;090A01-07  
Df(3R)Cha7 090F01-F04;091F05  
Df(3R)Dl-BX12 091F01-02;092D03-06 + 
Df(3R)H-B79 092B03;092F13  
Df(3R)e-N19 093B;094  
Df(3R)e-R1 093B06-07;093D02  
Df(3R)mbc-R1 095A05-07;095D06-11 + 
Df(3R)crb-F89-4 095D07-D11;095F15  
Df(3R)crb87-5 095F07;096A17-18  
 49 
Df(3R)slo[8] 096A02-07;096D02- 04  
Df(3R)Espl3 096F01;097B01  
Df(3R)Tl-P 097A;098A01-02  
Df(3R)D605 097E03;098A05  
Df(3R)3450 098E03;099A06-08  
Df(3R)L127 099B05-06;099E04-F01  
Df(3R)B81 099C08;100F05  
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FIGURES 
Figure 2.1. Cross scheme to test deficiency mutants for modification of the aret mutant 
phenotype.  
The inclusion of S1, which has a dominant visible rough eye phenotype, on the aretPD 
chromosome allows us to identify the S1 aretPD/Df(2L)esc-P2-0 individuals without 





Figure 2.2. Phenotypes scored in the screen.  
All panels are micrographs of ovarioles stained with DAPI (D) or ToPro-3 (all other 
panels) to highlight nuclei.  
A. Part of a wild type ovariole, including the germarium at left and several egg chambers 
of increasing maturity.  
B. Oogenesis is arrested at a very early stage in S1 aretPD/Df(2R)esc-P2-0 ovaries and 
the two ovarioles shown fail to bud off individual egg chambers. Instead, multiple 
undifferentiated germ cells appear in the severely truncated ovarioles.  
C. An example of a third chromosome deficiency, Df(3L)pbl-X1, that has no dominant 
effect on the starting phenotype.  
D. Df(3R)Dl-BX12 dominantly alters the starting phenotype, such that the germarium is 
greatly expanded to produce a large volume of germ cells surrounded by a layer of 
follicle cells.   
E.  Partial dominant suppression of the S1 aretPD/Df(2R)esc-P2-0 phenotype by 
Df(3R)M-Kx1. Egg chambers bud off from the germarium, although they are abnormal. 






Figure 2.3. Star interacts with aret 
The phenotypes of three aret allelic combinations of different strength are all dominantly 
enhanced by S1.  In each case the aret phenotype becomes more severe, largely 
mimicking the effect of using a stronger aret allelic combination. 
A. aretPD/Df(2R)esc-P2-0.   
B. S1 aretPD/Df(2R)esc-P2-0.   
C. aretPD /aretPA.   
D. S1 aretPD/aretPA.   
E. aretPD/aretQB.   




Figure 2.4. Grk protein accumulates in nurse cells of S1 aretPD/aretPA ovaries. 
Stage 7 egg chambers are shown for each genotype, with nuclei in red (ToPro-3) and Grk 
in green. In wild type egg chambers Grk protein is restricted to the oocyte (A). aret 
mutants (aretPD/Df(2L)esc-P2-0) also have detectable Grk only in the oocyte (B). When 
S1 is also present, in S1 aretPD/aretPA, ectopic Grk can be detected in the nurse cell 
cytoplasm (C) as well as the oocyte (C’, a different focal plane). Grk protein is also 
concentrated at nurse cell boundaries (arrows in D, a higher magnification view of a part 
of C). The aret mutant combination is stronger in B (aretPD/Df(2L)esc-P2-0) than in C 




Figure 2.5. Mutation and overexpression of Lk6 leads to opposite effects on the aret 
phenotype. 
Ovaries from aretPD/aretQB females arrest oogenesis at stage 6 or 7 (A), but the arrest is 
delayed when the females are also heterozygous for Df(3R)M-Kx-1/+ (B). A single copy 
of the EP(3)0886 P element insertion in Lk6 has a similar effect (C). Conversely, 
overexpression of Lk6 using EP(3)0886 and a germline GAL4 driver (mat 4-GAL4-
VP16#6) enhances the aret phenotype (D). The presence of the GAL4 driver alone does 
not change the aret phenotype (E).  In all cases the aret combination was aretPD/aretQB, 




Figure 2.6. Genetic interaction of Dl with aret. 
A. An arrested ovariole of an aretQB/aretQB female. Some of the egg chambers show an 
overproliferation of the germ line (identified by Vas, red staining in all panels; an 
example is shown at higher magnification in A'). Green staining in all panels is Hts. 
B.  An ovariole of an aretQB/aretQB; Dl9P/+ female. Only a single large egg chamber is 
present, and it has many germline cells. 
C-E. Higher magnification view to show the distribution of Hts, a fusome marker, in wild 
type (C), aretQB/aretQB (D) and aretQB/aretQB; Dl9P/+ (E). The fusome is branched 
and extends between cells in wild type (arrowheads), but appears as dots in both mutants 




Figure 2.7. The combination of aretPD/aretQB and Dl9P/+ mimics the Dl/Dl phenotype. 
A-C. The different classes of aretPD/aretQB; Dl9P/+  phenotypes. A shows a single 
large egg chamber that has formed by fusion or overproliferation. B and C show 
ovarioles with random or A/P incomplete egg chamber fusions, respectively. D and E are 
controls for comparison, aretPD/aretQB (D and D') and aretQB/+; Dl9P/+ (E and E'). 
The absence of stalk cells between incompletely fused egg chambers is shown in C', 
while stalk cells are visible in the controls (D' and E').  All panels show Hts staining, 




Figure 2.8.  aret mutant ovaries are deficient in Dl protein. 
A. Dl in wild type (A) and aretPD/aretQB (B) egg chambers. In each case the protein 
was detected by immunofluorescence using a confocal microscope with the same laser 
power and gain settings. In the wild type egg chambers, during stages 5-7, Dl is enriched 
at the surface of germline cells, especially where they appose follicle cells (A'), and 
dispersed throughout the cytoplasm. The overall distribution is similar in the aret mutant, 
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Deployment of Oskar protein at the posterior pole of the Drosophila oocyte relies 
on translational regulation. Bruno binds to BREs in the oskar mRNA and represses its 
translation, by a mechanism proposed to entail recruitment of Cup and thereby 
inactivation of eIF4E. Unexpectedly, Bruno mutants lacking a protein interaction domain 
and unable to bind Cup (and other proteins) still efficiently block accumulation of Osk. 
These mutants are indeed deficient in repression, but also prevent activation of oskar 
mRNA translation. Selective mutation of the two clusters of BREs in the oskar 3' UTR 
reveals opposing roles: BREs near the coding region act in repression, while BREs near 




Formation of the body plan of the Drosophila embryo relies on the action of 
several localized determinants [reviewed in (Lipshitz and Smibert, 2000; Palacios and St. 
Johnston, 2001)]. Bicoid (Bcd) protein, which is concentrated at the anterior of the 
embryo, specifies anterior fate. Two determinants - Oskar (Osk) and Nanos (Nos) act 
sequentially in posterior patterning. Osk protein is localized to the posterior pole of the 
oocyte and initiates formation of the pole plasm, which contains the activities for both 
posterior body patterning and germ cell formation. Nos protein is synthesized exclusively 
in or near the pole plasm, and serves as the localized component of the posterior 
patterning activity. Gurken (Grk) protein is highly concentrated at an anterodorsal 
position in the oocyte, and establishes the dorsoventral body axis. Each of these 
determinants has a potent patterning activity, such that overexpression or mislocalization 
can dramatically alter body patterning. For example, increasing the dosage of the osk 
gene progressively posteriorizes the embryo. Mild overexpression causes weak anterior 
defects, while higher levels lead to replacement of all head and thoracic segments with a 
mirror image duplication of posterior abdominal segments, the bicaudal phenotype 
(Smith et al., 1992). Similarly, specific misexpression of Oskar at the anterior efficiently 
produces bicaudal embryos (Ephrussi and Lehmann, 1992). Thus, proper deployment of 
the determinants is a critical step in embryonic pattern formation.  
Several mechanisms are used to ensure that the localized determinants appear 
only at the correct positions and in the desired amounts. The bcd, osk, nos and grk 
mRNAs are all prelocalized to the appropriate region within the oocyte or embryo (St 
Johnston, 1995). Each mRNA is also translationally regulated, such that protein 
distribution is dictated by the pattern of mRNA localization (Lipshitz and Smibert, 2000). 
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This translational control can be complex. In the case of osk mRNA, there is evidence for 
at least two forms of translational repression, as well as localization-dependent activation. 
Co-translational repression is achieved after initiation of translation, and prevents the 
accumulation of Osk protein from osk mRNA that is associated with polysomes (Braat et 
al., 2004). This phenomenon is reminiscent of microRNA (miRNA) mediated 
translational control (Bartel, 2004), and certain mutants with defects in the related 
process of RNA silencing accumulate Osk protein precociously (Cook et al., 2004; 
Tomari et al., 2004). Thus co-translational repression may involve miRNAs.  
A second form of repression is controlled by sequences in the osk mRNA called 
BREs, which are binding sites for Bruno (Bru) . The BREs are clustered in two regions, 
AB and C, at opposite ends of the osk 3'UTR: the AB region is near the coding region, 
while the C region is close to the polyadenylation site. Mutation of all of the BREs 
largely eliminates Bru binding in vitro and leads to precocious Osk protein expression in 
vivo, implicating Bru as a translational repressor (Kim-Ha et al., 1995; Webster et al., 
1997). A substantial body of evidence supports this conclusion, including the 
demonstration that Bru and BREs are required for repression in vitro (Castagnetti et al., 
2000; Lie and Macdonald, 1999a). 
The mechanism by which Bru represses osk mRNA translation appears to involve 
Cup. Mutants of cup display precocious accumulation of Osk, and Cup physically 
interacts with Bru. Cup, like a number of translational control factors, binds to translation 
initiation factor eIF4E. In doing so it prevents eIF4E from binding to eIF4G, an 
interaction that is required for conventional cap-dependent initiation of translation. Thus, 
Bru has been proposed to repress osk mRNA translation by recruiting Cup, which in turn 
binds eIF4E and blocks initiation (Nakamura et al., 2004). 
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Here we show that mutants of Bru unable to bind Cup (and other interactors) 
effectively block accumulation of Osk. Superficially, these results appear to be 
inconsistent with the model for Bru-mediated repression. However, complementary 
analyses of the roles of the different clusters of BREs in the osk mRNA and of the 
properties of interaction-defective Bru proteins reveal that Bru has two activities: the 
recognized role in repression, which may well require binding to Cup, and a novel role in 
activation of translation. Loss of both activities accounts for the phenotype of the 




Identification of a domain required for Bru dimerization  
Bru binds to several proteins, including Vasa (Vas)(Webster et al., 1997), Apontic 
(Apt) (Lie and Macdonald, 1999b), Cup (Nakamura et al., 2004) and itself (data 
presented here). Three of these interactions -- Bru/Apt, Bru/Bru (data presented here), 
and Bru/Cup -- can be monitored by the yeast two hybrid assay, providing a simple 
means of mapping the binding domain or domains of Bru. The Bru/Bru combination 
provides the most robust interaction, and was used for initial mapping experiments. Three 
groups of systematic deletion mutants were tested. In one group the RRM RNA binding 
motifs were removed, either individually or in combination. The two other groups of 
mutants consisted of progressively larger deletions from either the amino or carboxyl 
terminus of the protein. The results indicated that sequences between RRMs 2 and 3 
(amino acids 318-513; referred to as the interaction domain) are crucial for binding (data 
not shown). To confirm this conclusion, mutant proteins lacking part of the interaction 
domain were tested, as were proteins consisting of only the interaction domain (Fig. 
3.1A). When the first half of the interaction domain is deleted, the Bru/Bru interaction is 
severely disrupted, even though the level of the mutant protein is not dramatically 
reduced. The interaction domain alone binds to Bru and to itself, although the strength of 
the interaction is reduced. When the interaction domain is divided into two parts, the first 
half retains partial binding activity to full length Bru, but not to itself, and the second half 
does not bind Bru (Fig. 3.1B). These results strongly indicate that the interaction domain 
mediates Bru dimerization. 
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In an attempt to more narrowly define the important elements of the interaction 
domain, a library of randomly mutagenized plasmids expressing the domain were 
screened for binding to Bru. Two mutants defective in binding were identified from 
screening ~3000 transformants. One has a his to arg change at position 391 (H391R), and 
the other has two changes, gln 393 to his and gly 400 to glu (Q393H G400E; the mutant 
originally carried two additional mutations at positions 430 and 470, but removal of these 
mutations did not restore the interaction). To estimate the fraction of amino acids in the 
interaction domain tested by this approach, plasmids from 15 transformants that retained 
Bru binding in the assay were sequenced. They had from 1 to 9 amino acid changes in the 
interaction domain each, with a median of 2 changes. Thus about 2 x 3000 amino acid 
change mutations were sampled in the screen, and mutants with changes at most of the 
amino acids in the 195 amino acid interaction domain should have been tested. The low 
frequency at which binding mutants were recovered suggests that the interaction is 
relatively insensitive to single amino acid changes, and may thus involve a broad surface 
of the protein. Although the H391R and Q393H G400E mutants very strongly disrupt the 
interaction of the isolated interaction domain with Bru, when placed in the context of Bru 
they have little or no effect. Because the interaction domain/Bru binding is weaker than 
Bru/Bru binding, it appears to be more sensitive to changes.  
Two additional mutants that affect the Bru/Bru interaction were constructed (Fig. 
3.1A). An 8 amino acid deletion near the point mutants described above, Bru 382-389, 
has reduced binding, as does Bru::GFP, a protein created by fusion of GFP to the 
carboxyl terminus of full length Bru; presumably, fusion with GFP alters the 
conformation of Bru or limits accessibility to a binding surface, and thus impairs 
dimerization. 
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Bru dimerization mutants are also defective in Cup binding 
Bru mutants used to identify the domain required for dimerization were also 
tested for interaction with Apt and Cup (Fig. 3.1C). The interactions of Bru with itself 
and with Cup are similar, in that the Bru 334-416 mutant fails to bind to either protein, 
and the binding to Bru and Cup are reduced in proportionate degrees for Bru 382-389 
and Bru::GFP proteins. Furthermore, the isolated Bru interaction domain binds to both 
Bru and Cup. The only substantial difference is that the complete and partial interaction 
domains both bind to Bru, while only the complete domain binds to Cup. We confirmed 
that Bru 334-416 fails to bind either Bru or Cup using pull-down assays. GST::Cup and 
GST::Bru both bind Bru, but neither binds Bru 334-416 (Fig. 3.1D,E). 
The large and small deletions of the Bru interaction domain prevent or reduce 
binding to Apt, respectively. However, in contrast to the results with Bru and Cup, the 
isolated Bru interaction domain fails to bind Apt, and Bru::GFP retains strong Apt 
binding (Fig. 3.1C). Apt could bind to Bru via the interaction domain, with the varying 
sensitivities to the different mutants reflecting the use of a different part of the domain. 
However, because Apt does not bind to the isolated domain, we cannot exclude the 
possibility that Apt binds to a different part of Bru whose folding is indirectly altered as a 
consequence of a deletion within the interaction domain. 
Testing the role of the Bru interaction domain in vivo 
The Bru/Cup interaction has been proposed to mediate translational repression 
(Nakamura et al., 2004). By this model the mutants defective in Cup binding - Bru 334-
416, Bru 382-389 and Bru::GFP - are predicted to lack repressive activity. To investigate 
the role of the interaction domain in vivo, and to test this prediction, we relied on an 
overexpression assay. GAL4-driven expression (Brand and Perrimon, 1993) of a wild 
type bru cDNA under UAS control enhances repressive activity. Females expressing the 
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bru cDNA produce a large fraction of embryos lacking some or all abdominal segments, 
and Osk protein accumulation is reduced or undetectable (Snee et al., submitted; Figs. 3.2 
and 3). In this assay the transgenic Bru can compete with the endogenous protein for 
binding to BREs, allowing a mutant form of Bru to interfere with a Bru-dependent 
process. An alternate rescue assay, in which transgenic Bru is expressed in a aret mutant 
[the aret gene encodes Bru (Webster et al., 1997)], is not suitable. Although transgenic 
Bru does rescue, the rescue is not complete (Filardo and Ephrussi, 2003)(Snee et al., 
submitted). More importantly, aret mutants display no obvious defect in regulation of osk 
(Schüpbach and Wieschaus, 1991; Webster et al., 1997), and thus the rescue assay cannot 
be used to study the role of Bru in that process. 
Surprisingly, Bru mutant proteins impaired in Cup binding do not have the 
predicted phenotype. Each of the mutants is more effective than wild type Bru in 
producing embryos lacking abdominal segments (Fig. 3.2). Expression of wild type 
P[UAS-bru] in the ovary results in about 70% of embryos lacking all abdominal 
segments. For the interaction-defective mutants, ~80-95% of their embryos lack all 
abdominal segments. This enhanced inhibition of posterior patterning is accompanied by 
a more severe disruption of Osk accumulation: the fraction of oocytes with reduced or 
undetectable levels of Osk is dramatically increased (Fig. 3.3). These results appear to 
suggest that the interaction of Bru with Cup may not be required for translational 
repression of osk mRNA. An alternate interpretation, which accommodates the model 
that the Bru/Cup interaction mediates repression, is that Bru has an additional role in 
activation of osk translation. In this scenario the mutant Bru protein dominantly interferes 
with activation, and thereby obscures defects in repression. Two lines of evidence, one 
focusing on the Bru binding sites in osk mRNA, and one selectively assaying Bru 
repressive activity, support the latter interpretation. 
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The different BREs of osk mRNA have different roles 
Bru binds to multiple sites, BREs, in the osk mRNA 3' UTR. Some of the BREs 
are clustered in the AB region near the beginning of the 3' UTR, and others are in the C 
region close to the poly(A) tail. The original demonstration that Bru and the BREs act in 
repression of osk translation made use of an osk genomic DNA transgene (which in the 
wild type form rescues osk- mutants) in which all of the BREs had been inactivated by 
point mutations. Osk protein was expressed ectopically from this transgene, leading to 
excessive posterior patterning activity and the formation of posteriorized embryos with 
anterior defects or complete replacement of the anterior by a duplicated posterior (Kim-
Ha et al., 1995).  
We reevaluated the roles of the different BREs by testing similar osk genomic 
DNA transgenes in which the BREs of only a single region were mutated, either AB 
(P[oskAB-]) or C (P[oskC-]). Transgenes were introduced into osk+ females, and their 
embryos were examined for patterning defects. Two independent lines of each transgene 
were tested; there was some phenotypic variation between the different lines, but these 
differences were minor in comparison to the strikingly different consequences of 
mutating the different sets of BREs. 
Osk protein is limiting for posterior body patterning, and mothers with extra 
copies of the osk+ gene produce posteriorized embryos [(Smith et al., 1992); Fig. 3.4]. 
This activity is enhanced for the P[oskABC-] transgene, in keeping with previous results 
(Kim-Ha et al., 1995). The P[oskAB-] transgene causes even more pronounced 
posteriorization of the embryos. This elevated posterior patterning activity is consistent 
with a role for the AB BREs in translational repression. In contrast, the P[oskC-] 
transgene has dramatically reduced patterning activity, much less than that of the 
P[osk+] transgene: the vast majority of embryos from mothers with the P[oskC-] 
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transgene are wild type. The very limited activity of the P[oskC-] transgene is not a 
consequence of reduced transcription or mRNA stability, as the level of osk transcripts is 
similar in ovaries of flies expressing each of the transgenes (Fig. 3.5B). In addition, 
mutation of the BREs has no effect on osk mRNA localization (Kim-Ha et al., 1995).  
We extended analysis of the transgenes, examining levels of Osk protein in Osk 
protein-null [osk54/Df(3R)pXT103] host flies and their embryos (Fig. 3.5). In ovaries the 
level of Osk protein from the P[oskAB-] transgene is clearly greater than from the 
P[osk+] transgene. The P[oskABC-] transgene produces Osk at a level similar to that of 
the osk+ transgene [there is precocious accumulation of Osk (Kim-Ha et al., 1995), but 
this increase is minor when considered in the context of all of oogenesis, as in a western 
blot of ovaries], while the P[oskC-] transgene produces less Osk than any of the other 
transgenes. In early embryos (0-2 hours after egg laying) the elevation of Osk conferred 
by mutation of the AB region BREs is no longer apparent, while the reduction in Osk 
expression due to mutation of the C region BREs is more pronounced. The temporal 
complexities in Osk expression revealed in our analysis merit further attention. 
Nevertheless, the clear and important conclusion for this study is that the AB and C 
region BREs have very different roles, acting to repress and to activate osk mRNA 
translation, respectively.  
The Bru interaction domain is required for both translational repression and 
activation 
Our evidence that different BREs have negative or positive roles in osk mRNA 
translation is consistent with the notion that Bru acts in both repression and activation of 
translation. By this model the interaction-defective Bru mutants bind osk mRNA at the C 
region BREs but fail to recruit an activating factor, and thus dominantly block activation 
of osk translation. The interaction-defective Bru mutants could also be defective in 
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repression, as predicted by the model for the mechanism of Bru repression in which Bru 
recruits Cup. However, in the absence of the activating step the loss of repression might 
not be detected. Evidence that the interaction-defective Bru mutants are defective in 
repression would further support the assignment of an activating function to Bru. 
To test the interaction-defective Bru 334-416 mutant for repressive activity we 
developed an assay that selectively monitors BRE-dependent repression of translation. 
Expression of the osk coding region under UAS/GAL4 control and without the osk 3' 
UTR, in transgene P[UAS-osk], is translationally unregulated and the resulting embryos 
are bicaudal as a consequence of the ectopic osk activity [(Vanzo and Ephrussi, 2002) 
and Fig. 3.6]. Insertion of the osk AB region after the coding region of the transgene, to 
make P[UAS-osk-AB], confers translational repression: the bicaudal phenotype is 
eliminated and all embryos have either wild type or have minor patterning defects 
(including loss of anterior structures, which is indicative of a low level of ectopic osk 
activity). Mutation of the BREs, in P[UAS-osk-AB-], greatly reduces repression (Fig. 
3.6). Thus the P[UAS-osk-AB] transgene can be used to monitor the repressive activity of 
Bru independent of its presumed role in activation via the C region BREs. We can further 
increase the specificity of the assay by eliminating endogenous osk (in an osk- 
background), such that all osk-dependent effects on embryonic body patterning must 
reflect the activity of the P[UAS-osk-AB] transgene.  
If Bru 334-416 is defective in translational repression, then by competing with 
endogenous wild type Bru for binding to BREs it should interfere with repression of 
P[UAS-osk-AB] translation. The consequence would be increased ectopic Osk expression 
and enhanced anterior patterning defects. Expression of P[UAS-osk-AB] in osk- females 
produces embryos that lack all abdominal segments, since the P[UAS-osk-AB] transcripts 
are repressed and cannot rescue the osk mutant phenotype. A fraction of the embryos 
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have head defects, consistent with a low level of Osk accumulation due to incomplete 
repression (Webster et al., 1997). Co-expression of UAS-bru does not substantially alter 
the embryonic phenotype. However, co-expression of UAS-bru 334-416 significantly 
increases the proportion of embryos with anterior defects (Fig. 3.7). We conclude that the 
interaction-defective form of Bru interferes with repression, consistent with the model in 
which the Cup/Bru interaction underlies repression. Thus the ability of the mutant Bru 
protein to block accumulation of Osk translated from the endogenous osk mRNA is not 
because it is functioning as a repressor; instead, the mutant Bru protein presumably 
competes with endogenous Bru for binding to BREs (including those in the C region), 
fails to recruit or bind an activator, and thus interferes with Bru-dependent translational 
activation.  
Bru 334-416 binds BREs, and this activity is required to block Osk accumulation 
Our interpretation of the ability of Bru 334-416 to interfere with regulation of osk 
mRNA translation, both negative and positive, invokes a competition with endogenous 
Bru for binding to BREs. To confirm that Bru 334-416 retains BRE binding activity, 
UV-crosslinking assays were performed with ovarian extracts from females expressing 
the mutant protein. Both endogenous Bru and the transgenic Bru 334-416 bind to BRE 
RNA (Fig. 3.8). This binding activity is essential for the activity of Bru 334-416: a 
Bru 334-416 transgene bearing point mutations that largely abolish Bru RNA binding 
activity (D.H, J. Jen, M. Snee and P.M.M., unpublished) has no substantial effect on 




In the initial analysis of translational regulation of osk mRNA the BREs were 
defined as control elements that mediate repression. That conclusion was based on the 
phenotypic consequences of mutating all BREs: precocious expression of Osk, and body 
patterning defects (Kim-Ha et al., 1995). The subsequent development of in vitro 
translation systems that support Bru- and BRE-dependent translational repression 
reinforced the conclusion that Bru acts as a repressor when it binds to BREs (Castagnetti 
et al., 2000; Lie and Macdonald, 1999a). By selectively mutating the BREs from different 
parts of the osk 3’ UTR we have now revealed a more complex picture of the role of the 
BREs, which act in both repression and activation of osk mRNA translation. The 
bifunctional nature of the BREs raises the question of whether Bru also mediates 
activation, and evidence presented here strongly argues for such an additional role. 
Specifically, we find that a mutant of Bru defective in at least two of its protein/protein 
interactions – with itself and with Cup - can block accumulation of Osk, yet the mutant is 
defective in repression. We infer that the mutant is also impaired for the activation 
function mediated by the C region BREs. This discovery explains the enigmatic 
observation that reduction of the amount of Bru (in an aret heterozygote) can partially 
suppress the Osk overexpression phenotype of a Bic-C mutant (Castagnetti and Ephrussi, 
2003).  
Repression by Bru has been proposed to occur through interaction with Cup, 
which then locally inactivates eIF4E (Nakamura et al., 2001). Our results are consistent 
with this model, as disruption of the Bru/Cup interaction interferes with repression.  
The mechanism of translational activation by the osk C region BREs is unknown. 
Activation of other mRNAs often involves extension of the poly(A) tail, in a process 
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dependent on a cytoplasmic polyadenylation element (CPE) positioned close to the 
poly(A) tail, and a protein, CPEB, that binds to the CPE (Mendez and Richter, 2001). 
There is a CPE-like element (U8GU) almost immediately adjacent to the osk C region 
BREs, and the Drosophila CPEB protein, Orb, has a positive role in accumulation of Osk 
(Castagnetti and Ephrussi, 2003; Chang and Peter, 2002). Moreover, Orb has been 
reported to coimmunoprecipitate with Bru (Castagnetti and Ephrussi, 2003). Despite 
these indications, we have been unable to detect any alteration in poly(A) tail length 
when accumulation of Osk is very efficiently blocked by expression of the Bru 334-416 
protein (data not shown).  
Although the mechanism of Bru-dependent activation is unknown, several 
features of activation, and of the relationship between repression and activation, are 
noteworthy. First, the P[oskC-] transgene is not completely inactive, and produces some 
Osk. This could indicate that the C region- and Bru-dependent activation serves to 
enhance translation, but is not essential. This interpretation is not readily reconciled with 
the ability of the interaction defective forms of Bru to efficiently block accumulation of 
Osk. An explanation is suggested by a reexamination of Bru binding to the osk C region. 
The C region, as defined originally and used for in vitro RNA binding assays, 
corresponds to a 72 bp XbaI to Sau3A restriction fragment near the 3’ end of the osk 
transcript. Introduction of the BRE- mutations largely abolished Bru binding to an RNA 
from that fragment, and the same mutations were introduced into the complete osk gene 
to make the P[oskC-] transgene. We find that a larger version of the C region, extending 
to the polyadenylation site, is a better substrate for Bru binding. Given this result, there 
are probably additional Bru binding sites in the larger C region, and these are not mutated 
in the P[oskC-] transgene. Consequently, the P[oskC-] transgene may retain partial 
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activation function, which would allow a low level of Osk to accumulate as is observed. 
Thus, the C region-dependent activation may well be essential. 
Knowing when Bru-dependent activation occurs could provide insight into the 
mechanism. Bru could act prior to localization of osk mRNA by making the mRNA 
competent for translation, an activity that would initially be masked by the 
contemporaneous repression that prevents accumulation of Osk. Bru could act coincident 
with osk mRNA localization, overriding repression and triggering the onset of Osk 
accumulation. Or Bru could act after osk mRNA localization, during the late stages of 
oogenesis when there is substantial accumulation of Osk protein and a mechanism may 
exist to enhance translation (Snee et al., submitted). At present we are unable to rule out 
any option. It might appear that Bru cannot simply override its own form of repression, as 
loss of both activating and repressing Bru activities would lead to elevated Osk: this is 
not observed. However, the Bru 334-416 protein is more effective in dominantly 
interfering with activation than with repression, at least in the assays used, and we cannot 
predict the overall effect of inhibiting both processes to different extents. One suggestion 
about the timing of Bru activation comes from the pattern of Osk accumulation from the 
P[oskC-] transgene. Mutating the C region BREs reduces the level of Osk, both when 
tested in ovaries and in early embryos. However, the effect is strongest in embryos, 
raising the possibility that the activation step is specifically involved in a late phase of 
Osk accumulation. Recent evidence demonstrates that much of Osk protein appears very 
late in oogenesis (Snee et al., submitted), and this phase of expression might be subject to 
stage-specific forms of control. 
One intriguing question about the dual roles of Bru is why binding to one set of 
BREs results in repression, while binding to other BREs confers activation. There are 
many situations in which a single type of binding site can exert either positive or negative 
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effects on gene expression, depending on which proteins are bound; the family of basic 
helix-loop-helix transcription factors provides a general example. However, it is much 
less common for a single nucleic acid binding protein to have opposing effects dependent 
on which regulatory site it binds, and for the protein to play a more positive role in each 
process than simply preventing another factor from binding to the regulatory site.  
We envisage three possible models for the two functions of Bru (Fig. 3.9). In the 
first, Bru can recruit the same spectrum of factors independent of its binding site, but the 
consequences of Bru binding depend on its position within the mRNA. For example, 
binding at any site might promote repression, while activation would only be possible 
when Bru binds and recruits an activator in the immediate vicinity of the poly(A) tail. In 
the second model the different activities depend on other factors that can bind near Bru. 
For example, the osk C region might contain a binding site for a factor that cooperates 
with Bru to mediate activation. By the current model for Bru- and Cup-dependent 
repression, no protein binding near Bru in the osk AB region would be necessary, 
although there is no reason to exclude such a possibility. Finally, a third model invokes 
qualitative differences in the Bru binding sites in the AB and C regions of the osk 3’UTR. 
In this model the nature of the RNA substrate would dictate how Bru acts. For example, 
when bound to the AB region Bru might assume a conformation that enhances interaction 
with a repressive binding partner, such as Cup. Adoption of a different conformation 
when bound to the C region might favor binding of Bru to an activator.  
Although we cannot yet distinguish between these models (and features of more 
than one could contribute to the actual mechanism), there is one intriguing difference 
between the Bru binding sites of the AB and C regions. The BREs were initially defined 
as a consensus sequence of U(A/G)U(G/A)U(A/G)U, but this description is probably 
incomplete. For example, the D. virilis osk mRNA 3’ UTR also binds Bru, but in the AB 
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region there is only a single copy of the consensus, as opposed to four in the D. 
melanogaster osk AB region (Webster et al., 1994). Notably, EDEN-BP, a protein whose 
RRM RNA binding motifs are very closely related to those of Bru (Paillard et al., 1998), 
binds to multimers of UAUG or UGUA (Bonnet-Corven et al., 2002), sequences 
embedded within the BREs. There are seven copies of these tetranucleotides in the osk 
AB region (and the same number for D. virilis), and all are disrupted by the mutations 
that abrogate Bru binding. Similarly, there are four copies of the tetranucleotides in the C 
region, as originally defined, with all affected by the BRE- mutations (the D. virilis C 
region also has 4 copies). Thus, it seems likely that the Bru recognition site contains one 
or more copies of the tetranucleotides. In the AB region most copies of the 
tetranucleotides are separated from one another by gaps. In contrast, in the C region the 
tetranucleotides are invariably overlapping. This general pattern holds for the osk AB and 
C regions of all Drosophila species that have been sequenced. These differences between 
the AB and C regions might influence how Bru binds, and either directly or indirectly 
affect its conformation and choice of binding partners. 
MATERIALS AND METHODS 
Flies and transgenes 
w1118 flies were used as the wild-type. All mutant flies are as described at 
FlyBase (http://flybase.bio.indiana.edu/). P[UAS-bru] and P[UAS-bru::GFP] were 
described previously (Snee and Macdonald 2004). P[UAS-bru 334-416] and P[UAS-
bru 382-389] were constructed by deleting the PflMI-NotI fragment or PstI-PstI 
fragment from full-length bru cDNA, respectively; ligation restores the correct reading 
frame. The modified bru cDNAs were substituted into the P[UAS-bru] transgene. The 
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nosGAL4VP16 (Van Doren et al., 1998) and maternal alpha tubulin (Martin and St 
Johnston, 2003) GAL4 drivers were used to express UAS transgenes.  
The P[osk+] and P[oskABC-] transgenes were described previously (Kim-Ha et 
al., 1995). In the P[oskABC-] transgene the mutant AB region has the sequence 
GAATTCGCTTAGTTTTAATTAGTTTTTAATTTTCCATTGTTCTCTGTCTTTGTTA
TTTTAGATTTTCGTGCACTTGTCCTAGTCCATTATTTTAGATTATTTTGGGTTT
TGGTTTCTTAGTTAGATTTAAA (an EcoRI-DraI fragment), and the mutant C region 
has the sequence 
TCTAGATAGCTATCTACTATTTATAAACTTATTTATTGTCTTGAATTTGAGTTA
ACTTGAGTTATTGATGGTGATC (an XbaI-Sau3A fragment). The P[oskAB-] and 
P[oskC-] transgenes contain the same genomic DNA fragment as P[osk+] and 
P[oskABC-] and are wild type except for the mutations within the AB or C regions, 
which are as described above.  
The UAS-osk series of transgenes contain the osk coding region as a BamHI 
fragment inserted into the BamHI site of the pUASp vector (Rorth, 1998). The osk coding 
region fragment is largely from an osk cDNA, except that a short genomic segment 
beginning at the BamHI site was added to the 5' end, and the 3' BamHI site was 
introduced just after the stop codon. For P[UAS-osk-AB] and P[UAS-osk-AB-] the wild 
type or mutant AB region was first inserted into the BamHI site of pUASp as a BamHI-
BglII fragment prior to addition of the osk coding region. 
Transgenic flies were generated following standard procedures. 
Yeast two hybrid assays and mutagenic PCR screen 
The full-length bru cDNA was subcloned into yeast vector pGilda (Clonetech). 
Systematic deletion mutants were generated using PCR and subsequently cloned into 
yeast vector pJG4-5. The full-length apontic cDNA was subcloned into pJG4-5 as 
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described (Lie and Macdonald, 1999b). The cup cDNA in yeast vector pGAD10 was a 
gift from Robin Wharton (Verrotti and Wharton, 2000). Yeast stain EGY48 was 
transformed with reporter plasmid pRB1840 (Golemis and Brent, 1997) and appropriate 
two hybrid plasmids. -Galactosidase activity was determined using a liquid assay 
(Burke et al., 2000). 
pJG4-5-ID::GFP was constructed by subcloning a GFP cDNA at the 3’ end of a 
bru cDNA fragment that encodes the interaction domain (amino acids 318-513). The 
resulting plasmid served as the DNA template for mutagenic PCR. The PCR mixture 
contained: 0.4 μg DNA template, 1 X Taq polymerase buffer (Invitrogen), 0.8 mM 
dNTPs (Promega), 18 pmol primers, 5 unit of Taq polymerase (Invitrogen) and 0.2 mM 
MnCl2 in a 100 μl reaction. The 5’ primer is 5’-
TCCTACCCTTATGATGTGCCAGATTATGCCTCTCCCGAATTGGCTCGAGCCAA
TCTCTGGAAC-3’. The 3’ primer is 5’-
AATTGGGACAACTCCAGTGAAAAGTTCTTCTCCTTTACTCATGGTACCCCGCA
GCGGCGA-3’. PCR reactions were done with 60°C as annealing temperature and 
repeated 30 cycles. 40 μl of PCR-amplified fragments were co-transformed with 100 ng 
pJG4-5-ID::GFP (gapped with EcoRI and blunt-ended with Klenow polymerase) into 
yeast carrying pGilda-bru and reporter pRB1840. Transformants were grown on glucose 
plates selecting for the presence of all plasmids and subsequently replicated to galactose 
plates assaying for interaction. Colonies on galactose plates were scaned in a FluorImager 
SI (Molecular Dynamics) for the presence of GFP signal to eliminate PCR events which 
resulted in nonsense mutations or frame shifts. Colonies that tested positive for GFP 
signal and failed to show interaction with Bru were selected as positives. DNAs were 
subsequently extracted from these positive clones and insertions were analyzed by 
sequencing. 
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Protein expression in E. coli and GST pull-down assays 
GST::Bru was constructed by subcloning full-length bru cDNA into pGEX-2T 
(Amersham). GST::Cup was a gift from Robin Wharton (Verrotti and Wharton, 2000). 
The Bru proteins used for binding were tagged at the amino terminus with six histidine 
residues, and were expressed using pET15b (Novagen) in E. coli CodonPlus RP/RIL 
(Stratagene). GST::Bru, GST::Cup or GST alone was first immobilized on glutathione 
sepharose (Amersham) and subsequently incubated with his-tagged Bru or Bru 334-416 
for 1 hour. The beads were spun down, washed with GST binding buffer (50 mM Tris-
HCl [pH 7.5], 150 mM NaCl, 1 mM DTT, protease inhibitors, 10% Glycerol) and boiled 
in SDS loading buffer. Elutes were separated by SDS PAGE and analyzed by western 
blotting. Rat anti-Bru antibody was used at 1:20,000 to detect Bru protein. 
Detection of proteins and mRNAs 
Immunostaining and in situ hybridization of ovaries were carried out as described 
(Kim-Ha et al., 1995). Rabbit anti-Osk antibodies were used at 1:2,000. Rat anti-Stau 
antibodies were used at 1:100. Microscopy of all samples made use of a Leica TCS-SP 
laser scanning confocal microscope. 
Ovaries from ~20 females, fed on yeast for 2-3 days, were dissected in PBS and 
immediately transferred to 50 μl 1xSDS loading buffer. Ovaries were homogenized in 
1xSDS loading buffer, boiled for 5 minutes and spun for 10 minutes at 13,000 rpm. The 
supernatant was used for western analysis. Early (0-2 hour) embryos were collected on 
yeasted apple juice plates, dechorionated in 50% bleach for 3 minutes, and immediately 
transferred to 50 μl 1xSDS loading buffer. Embryos were subsequently treated  the same 
as ovaries for western analysis. 
Ovaries from ~10 females, fed on yeast for 2-3 days, were dissected in PBS and 
immediately transferred to 250 μl Native Buffer (50 mM Tris [pH7.4], 0.25 M KCl, 25 
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mM MgCl2, 50 units/ml RNase inhibitor 1 μg/ml pepstatin, 1 μg/ml leupeptin, 5 mM 
benzamide, 0.5 μM Pefabloc) on ice.The ovaries were washed, resuspended in 250 μl 
Native Buffer and homogenized. 750 μl Tri-Regent LS (Molecular Research Center, Inc) 
was added and RNA was extracted according to the manufacturers protocol. Finally, 
RNA was resuspended in 20 μl water (DEPC treated) and 1 μl was used for the RNase 
protection assay (Ambion, Inc). 
UV cross-linking 
RNA binding assays were performed as described (Kim-Ha et al., 1995) with 
ovary extract and probes from the osk AB (EcoRI to DraI) and C (XbaI to XbaI) regions.  
Phenotypic analysis 
Embryos were collected from young females in small population cages, aged for 
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FIGURES 
Figure 3.1. A domain of Bru mediates dimerization and interaction with Cup. 
(A) Schematic diagram of wild type and mutant Bru proteins. The three RRM (Burd and 
Dreyfuss, 1994) RNA binding domains are lightly shaded, and GFP (not to scale) is dark 
grey. (B-C) Interactions measured by yeast two hybrid assays, with panel B showing 
interactions between various forms of Bru and panel C showing interaction of various 
forms of Bru with full length Bru, Apt and Cup. The strength of the interaction, as 
estimated by level of -galactosidase activity, is denoted by the number of +'s where each 
+ corresponds to 5 units of activity (Burke et al., 2000). 
(D-E) Bru 334-416 fails to interact with GST::Cup (D) and GST::Bru (E) in protein pull-
down assays. GST fusion protein or GST alone attached to glutathione-sepharose beads 
was incubated with Bru or Bru 334-416 proteins from E. coli. The amount of bound 
protein was detected by Western blotting with anti-Bru antibody. The positions at which 
Bru and Bru 334-416 (labeled Bru ) migrate are indicated at left. Lanes 1 and 2 in both 
panels represent 20% of the amount of input protein in the other lanes. In panel E the 
GST::Bru protein is partially degraded, as evident from lane 5. The stronger bands of 
degraded protein in lanes 3-5 are indicated with dots. Note that the strong band of input 
Bru in lane 3 migrates apart from the GST::Bru degradation products, and the position at 




Figure 3.2. The Bru interaction domain is not required for efficient inhibition of posterior 
body patterning activity. 
Examples of the different classes of cuticular phenotypes are shown in A-D, 
ranging from wild type (A) to partial (B and C) or complete (D) loss of abdominal 
segments. The distribution of embryos in the different classes is presented in E for two 
independent transgenic lines each of P[UAS-bru] and the three interaction-defective bru 
mutants. For all genotypes one copy of the UAS transgene was present, and the GAL4 
driver was a single copy of nosGAL4VP16. The nosGAL4VP16 driver by itself causes a 




Figure 3.3. Interaction-defective forms of Bru display enhanced ability to block 
accumulation of Osk protein. 
Osk (A-E) and Stau (F-J), which also serves as a marker for the distribution of osk 
mRNA, were simultaneously detected in stage 10 oocytes. The oocyte in A and F is wild 
type, while the remaining four oocytes are expressing forms of Bru under UAS/GAL4 
control (the nosGAL4VP16 driver was used). The examples in B-E correspond to the 
categories of Osk protein level and distribution indicated in the summary in panel K: 
normal Osk in B, reduced Osk in C, little or no detectable Osk in D, and Osk in a 
'floating body' in E. The persistent posterior concentration of Stau, even when Osk levels 
are greatly reduced , indicates that osk mRNA localization is relatively normal and thus 
not affected by the Bru mutant proteins. The floating bodies are very rare, and only seen 
in significant numbers when P[UAS-bru::GFP] is expressed. Two observations suggest 
that they form by detachment from the posterior cortex. First, in some examples they 




Figure 3.4. BREs in the osk mRNA AB and C regions have different roles. 
  (A-C) Examples of different classes of cuticular phenotypes from embryos of 
mothers expressing wild type or BRE- versions of transgenic osk, in addition to 
expression of the endogenous osk+ gene. A, anterior defects; B, bicaudal; and C, severe 
bicaudal. (D) Distribution of embryos in the different phenotypic classes. Data are 
presented for two independent transgenic lines for each transgene. In all cases the females 






Figure 3.5. Mutation of osk AB and C BREs have opposing effects on Osk accumulation. 
(A) Protein accumulation from wild type and BRE- osk transgenes, monitored by 
western blot analysis in ovaries and embryos. All transgenes were tested in the protein 
null osk54/Df(3R)pXT103 background, and so the Osk signal is due entirely to expression 
from the transgene. Tubulin levels were monitored in the same samples to control for 
differences in the amount of protein among different genotypes. In ovaries the oskAB- 
transgene directs accumulation of the most Osk, while the lowest levels are observed for 
the oskC- transgene. The deficit in Osk accumulation from the oskC- transgene is even 
more pronounced in early (0-2 hour) embryos, while the oskAB- transgene now behaves 
more like osk+. 
(B) Levels of osk mRNAs in transgenic flies. RNase protection assays were performed on 
ovarian RNA from flies expressing no transgene (w1118) or a single copy of the 
indicated transgene. The assay detects both endogenous and transgenic osk transcripts, 
but does not distinguish between them. Levels of rp49 mRNA were assayed in the same 
samples to control for differences in amount of RNA in the different genotypes. The 
substantial differences in Osk protein accumulation from different transgenes seen in 





Figure 3.6. Assay system that selectively monitors osk AB region-dependent repression 
of translation. 
Transcripts produced by the P[UAS-osk], P[UAS-osk-AB] and P[UAS-osk-AB-] 
transgenes are shown in schematic form, and differ only in the presence of the ~120 nt 
AB region which is either wild type or bearing the BRE- mutations described above. 
Portions of the osk mRNA are shown as a thick black line (5' UTR sequences in both 
transcripts and the osk AB 3' UTR region in the UAS-osk-AB and UAS-osk-AB- 
transcripts) or a shaded rectangle (coding region). The common 3' UTR (undulating line) 
is a part of the fs(1)K10 mRNA which is present in the pUASp vector (Rorth, 1998) and 
does not include the TLS localization element (Serano and Cohen, 1995). The AB region 
is not sufficient to direct posterior localization (Kim-Ha et al., 1993), and as expected the 
P[UAS-osk-AB] transcripts are not localized (data not shown). The transcripts contain 
additional 5' UTR sequences from the pUASp vector which are not shown.  
 Expression of the transgenes in females with the maternal alpha tubulin GAL4 
driver produces dramatically different phenotypes, as expected given the role of the AB 






Figure 3.7. Bru mutant protein unable to bind Cup interferes with translational repression 
by wild type Bru. 
To selectively monitor osk AB-dependent repression, wild type and interaction-
defective forms of Bru were expressed in osk- females also expressing the P[UAS-osk-
AB] reporter transcript. Expression of Osk from P[UAS-osk-AB] interferes with anterior 
development, and a low level of osk activity owing to incomplete repression via the AB 
region produces ~20% of embryos with an incomplete head skeleton (weak anterior 
defect, panels B and C) or absence of head involution and head skeleton (strong anterior 
defect, panel D). Panels A-D show complete larval cuticles, while A'-D' show the head 
regions in greater detail. As summarized in panel E, expression of P[UAS-bru] in this 
background has little effect on patterning, while expression of P[UAS-bru 334-416] 
dramatically enhances the anterior defects. The maternal alpha tubulin GAL4 driver 
(abbreviated as MAT2) was used for expression of the UAS transgenes.  
The absence of any substantial rescue of abdominal segmentation in this assay is 
presumably because the UAS-osk-AB mRNA is not localized to the posterior. Expression 
of an unlocalized form of nanos mRNA also disrupts anterior development more 





Figure 3.8. Bru 334-416 retains BRE binding activity. 
(A) Binding to labeled BRE probes from the osk AB or C regions was measured 
by UV crosslinking assay with ovary extracts from wild type flies (w1118) or from flies 
expressing P[UAS-bru 334-416] (under control of the nosGAL4VP16 driver), as 
indicated. The AB and C transcripts are wild type, and the AB- and C- transcripts have 
point mutations in the BREs. The C RNA is larger than used previously (see 
Experimental Procedures), and bind better to Bru (data not shown). The larger C- RNA 
retains reduced but still detectable binding to Bru. Bru 334-416 binds to both AB and C 
probes. Bru binds the AB probe more strongly than the C probe. This preference is lost 
for the Bru 334-416 protein, a reproducible result of unknown significance. 
(B) Detection of Bru proteins in ovary extracts of wild type (lane 1), P[UAS-bru] 
(lane 2) and P[UAS-bru 334-416] (lane 3)(the w1118 and P[UAS-bru 334-416] extracts 
are the same as those used in panel A). Bru and Bru 334-416 proteins were detected by 
Western blotting with anti-Bru antibody. The Bru 334-416 protein is not substantially 





Figure 3.9. Models of Bru action as both repressor and activator of translation.  
 The three models are described in the text. Bru is indicated as a gray oval. A Bru-
interacting protein involved in activation is indicated as ?. Postulated Bru binding 
partners that interact specifically with osk AB or C regions and contribute to repression 
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ABSTRACT 
cis-acting elements in the 3’UTR of mRNAs often have important roles in 
translational regulation. Trans-acting factors can bind to these elements and regulate the 
expression of the mRNA. A well-established example in Drosophila is translational 
regulation of the oskar mRNA by Bruno. Bruno binds to two different regions (the AB 
and C regions) of the oskar mRNA 3’UTR and displays opposite functions (repression 
and activation) upon binding. In this study, we explored in detail how Bruno binds to its 
RNA targets using a quantitative assay. We find three notable features displayed by 
Bruno binding: high affinity, cooperative binding and apparent RNA compaction. Each 
of these features is evident for binding of Bru to the AB region, but binding to the C 
region is qualitatively and quantitatively different. These substantial differences in 
binding provide support for a specific model to explain the dual action of Bruno. We also 
find that Bru dimerization is not required for its cooperative binding to AB RNA. Instead, 
a complete AB region is required for all features of Bruno binding, supporting the idea 




Many important developmental processes in Drosophila, such as body patterning, 
are regulated by genes that are subject to post-transcriptional regulation. This regulation 
often involves cis-acting elements in the 3’UTRs of the mRNAs. Some elements direct 
mRNA localization while others regulate translation (Johnstone and Lasko, 2001). 
Translational regulation can affect a variety of steps, including ribosome binding, 
scanning, initiation and elongation (Kuersten and Goodwin, 2003). One example is 
translational regulation of the oskar (osk) mRNA by Bruno (Bru). Bru binds to two 
different regions of the osk mRNA 3’UTR: the AB region close to the osk coding 
sequence and the C region close to the polyadenylation site (Kim-Ha et al., 1995). Data 
from Chapter 3 suggest that Bru has a dual role on osk translation: it acts as a repressor 
when it binds to the AB region BREs, and it acts as an activator when it binds to the C 
region BREs. The molecular basis for this dual action is unclear, but the nature of how 
Bru binds to its target sites may be an important part of the decision to repress or activate. 
In this study, we explore in detail the interaction of Bru with its targets. 
We have proposed three different models by which Bru can have a dual role in 
osk translation. The first model is the ‘binding partner model’, in which additional 
proteins bind selectively to either the AB or C regions, and through interaction with Bru 
determine how Bru will function. At present, there are no candidates for such co-factors, 
making the model difficult to test. The second model is the ‘position model’, in which the 
relative position in the mRNA to which Bru binds determines how Bru will act. For 
example, proximity to the poly(A) tail might allow Bru to perform a function involving 
polyadenylation, while binding in a different region might preclude that function or 
promote another. This model is being tested by others in the lab. The third model is the 
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‘instructive substrate model’, in which the nature of the RNA substrate influences Bru’s 
function. For example, when Bru binds to BREs in the AB region, it could adopt one 
conformation that recruits the repression machinery, whereas binding to BREs in the C 
region could lead to an alternative conformation with high affinity for the activation 
machinery. One fundamental difference between the last two models is that the final 
model posits a difference in how Bru binds the two regions, or in the effect of binding on 
Bru (such as its structure). All of the previous analyses of Bru/RNA binding relied on UV 
crosslinking assays (Filardo and Ephrussi, 2003; Kim-Ha et al., 1995). Here we use a 
more quantitative method to study the binding of Bru to the AB and C regions.  
We find three notable features displayed by Bru binding: high affinity, 
cooperative binding and apparent RNA compaction. Each of these features is evident for 
binding of Bru to the AB region, but binding to the C region is qualitatively and 
quantitatively different. In addition, we find that Bru dimerization is not required for its 




Quantification of Bru binding to osk AB RNA 
We performed gel mobility shift assays to investigate the binding of Bru to RNA 
substrates from the osk 3’UTR. This assay has been successfully used by others to 
evaluate protein/nucleic acid binding (Batey and Williamson, 1996a; Dubey et al., 2005; 
Magnet and Blanchard, 2004; Melo et al., 2003; Recht and Williamson, 2004; Ryder et 
al., 2004). In this assay, a constant level of radiolabled AB RNA was mixed with 
increasing amounts of recombinant Bru protein and allowed to bind at room temperature. 
Bru/AB RNA complex and free AB RNA were separated on a native gel (Fig 4.1B). 
Quantitation of the assay determines Kd, the apparent equilibrium dissociation constant, 
as well as cooperativity, which is measured by the Hill coefficient. No cooperativity 
corresponds to a Hill coefficient of 1, while a value greater than 1 indicates positive 
cooperativity. 
100% binding was achieved at high Bru concentrations, with Bru/AB RNA 
complex and free AB RNA migrating to different positions (Fig 4.1B). Only a single 
complex was observed with increasing amounts of Bru. The percentage of RNA bound at 
various Bru concentrations was determined, and the data were analyzed using the Hill 
equation (see Materials and Methods). Our analysis revealed that Bru has high affinity for 
AB RNA (Kd=39 nM). Notably, binding of Bru to AB RNA is also highly cooperative 
(Hill coefficient of 1.7 to 2.0).  
The appearance of only a single Bru/AB RNA complex was not expected. AB 
RNA contains multiple Bru binding sites (Kim-Ha et al., 1995), suggesting that there 
would be complexes that differ in the number of molecules of Bru bound. The absence of 
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any intermediate binding complex raises the possibility that Bru binds to AB RNA in a 
rapid ‘all on or all off’ fashion. This type of behavior is common when binding is 
cooperative: the binding of the first ligand lowers the energy required for the second 
ligand to bind to the same substrate, and the substrate reaches full occupancy very rapidly 
(Edelstein, 1975). Binding of Bru to AB RNA is highly cooperative, which can explain 
the appearance of a single complex. An alternative explanation is that under the 
conditions of the assay intermediate complexes, with only a subset of the binding sites 
occupied, are not stably associated with the RNA during electrophoresis. Therefore only 
the fully occupied complex is detectable. 
We also find that Bru/AB RNA complex migrates in the native gel faster than free 
AB RNA, a phenomenon known as band acceleration (Batey and Williamson, 1996a). 
Typically, if a nucleic acid has the same structure when it is both free and bound, then 
protein/nucleic acid complexes will migrate more slowly than free nucleic acid when 
subjected to native polyacrylamide gel electrophoresis (Revzin, 1989). Bru protein would 
be expected to retard migration of the RNA. Because we observe increased migration, it 
appears that a change in the structure of the RNA is responsible. Specifically, the RNA 
appears to be compacted upon binding of Bru. Notably, Bru does not inherently 
accelerate migration of all target RNAs (data below), consistent with this interpretation.  
There are precedents in which compaction of an RNA upon protein binding leads 
to band acceleration in a gel mobility shift assay. One example involves the interaction of 
ribosomal protein S15 with a substrate from the central domain of 16S rRNA, which 
corresponds to the first step in assembly of the 30S ribosomal subunit (Batey and 
Williamson, 1996a; Batey and Williamson, 1996b). Binding of S15 leads to increased 
mobility of the RNA. Structural data show that S15 binding is coupled to a 
conformational change in a three-helix junction of the RNA, consistent with the 
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interpretation that compaction of the RNA is responsible for accelerated migration 
(Agalarov et al., 2000). Another example is Alfalfa mosaic virus (AMV) coat protein 
(CP), which is required to activate viral RNA replication in an infected cell. AMV CP 
shows band acceleration upon binding to a viral RNA substrate. The RNA binding 
domain (RBD) of the CP binds to AUGC tetranucleotide repeats in the 3’UTR of the 
viral RNA to form a structurally organized 3’ terminus, and this change in RNA structure 
can account for the observed band acceleration (Guogas et al., 2004; Petrillo et al., 2005). 
Bru binds differently to osk AB and C regions 
To further investigate the reason why the binding of Bru to AB and C regions in 
the osk 3’UTR leads to opposite functions in translation, we compared these two binding 
events. The C RNA used was a 192 nt RNA that includes all recognizable BREs in the C 
region and extends to the 3’ end of the osk 3’UTR (Fig 4.1A). Bru binds to C RNA with 
three times lower affinity (Kd=125 nM) compared to AB RNA (Kd=39 nM). This 
quantitative difference in binding of Bru to the two substrates is accompanied by 
qualitative differences: binding to the C RNA is not cooperative (Hill coefficient=1.1), 
and does not display band acceleration (Fig 4.1C). 
A complete AB region is required for all features of Bru binding  
The striking difference in how Bru binds AB and C RNAs raises the question of 
what part of the AB substrate is required for cooperative binding and the apparent 
compaction of the RNA. To address this question we tested mutant AB RNAs in which 
some but not all of the Bru binding sites were modified by point mutations or removed by 
terminal deletions (for a diagram see Fig 4.2A). The A and B RNAs consist of the 5’ and 
3’ portions of AB, respectively (details see Materials and Methods). The sAB RNA 
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(Gunkel et al., 1998) contains only the central 80 nt of AB. The A+B- RNA includes 
point mutations that disrupt the Bru binding sites in the B portion of AB. 
All RNAs from which some Bru binding sites are removed by deletions show low 
affinity for Bru. sAB RNA has Kd of 1 uM and A and B RNA have Kds of greater than 1 
uM (Fig 4.2B). The Hill coefficient could not be determined due to poor binding. All 
three RNAs show retarded complex migration, indicating the RNAs are not compacted 
the same way as AB RNA is.  
The RNA in which some Bru binding sites were disrupted by point mutations also 
displays both quantitative and qualitative differences, relative to AB RNA, in how it 
binds Bru. The affinity is substantially reduced, with a Kd of 256 nM (vs 39 nM for AB 
RNA), and binding is only weakly cooperative (Hill coefficient=1.3) (Fig 4.2B). This 
residual cooperativity may come from the wild type BREs in the 5’ half of A+B- RNA. 
Binding of Bru to the A+B- RNA retards its migration, indicating that binding sites in B, 
or the presence of all binding sites in AB, is required for band acceleration and apparent 
compaction of AB RNA. 
Cooperative Bru binding -  Bru dimerization is not required 
One of the notable features of Bru binding to AB RNA is cooperativity. Many 
proteins display cooperative binding for their nucleic acid substrates. Often, cooperative 
binding is achieved through protein homo- or hetero-dimerization. Binding of the first 
protein brings along or recruits the second, which can bind to the same substrate easier. 
Many examples of DNA binding proteins display this phenomenon (Courey, 2001; 
Koudelka, 2000). An RNA binding protein for which dimerization underlies cooperative 
binding is the poly(A)-binding protein (PABP). PABP binds to a conserved A-rich 
sequence present in the 5’UTR of its mRNA and represses translation. The cooperativity 
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of this binding is dependent on a C terminal domain of PABP that mediates dimerization 
(Melo et al., 2003).  
Another type of cooperative binding, which is rare among studied examples, is 
not induced by protein/protein interaction. Instead, binding of the first protein alters the 
nucleic acid substrate and makes it more suitable for binding of the second protein. One 
example involves an interaction previously mentioned - S15 binding to an RNA from the 
central domain of 16S rRNA, which corresponds to the first step in assembly of the 30S 
ribosomal subunit. The second step in 30S subunit assembly is the binding of the S6:S18 
heterodimer to the central domain of 16S rRNA. The two assembly steps display 
cooperativity. Biochemical and structural data show that the cooperativity can be 
assigned to a structural change in the RNA - this change is induced by S15 binding and 
facilitates binding of the S6:S18 heterodimer (Agalarov et al., 2000; Capel and 
Ramakrishnan, 1988; Recht and Williamson, 2004). 
Bru forms dimers, and the interaction domain has been defined. To determine if 
dimerization is required for cooperative binding of Bru to AB RNA, we tested the RNA 
binding properties of a Bru mutant, Bru 334-416, which cannot dimerize (see Chapter 3; 
for a diagram see Fig 4.3A). Bru 334-416 has slightly weaker affinity for binding to AB 
RNA (Kd = 112 nM) compared to Bru (Kd = 39 nM). Nevertheless, the binding of 
Bru 334-416 to AB RNA retains positive cooperativity, and this may actually be 
enhanced (Hill coefficient=3.2, Fig 4.3B). In addition, Bru 334-416 also displays band 
acceleration upon binding to AB RNA as if the RNA is compacted (Fig 4.3B). Thus, 
dimerization is not required for cooperative binding of Bru to AB RNA. Moreover, the 





We have shown that Bru binds with different properties to substrates having 
different biological roles. Bru binding to AB RNA is cooperative, and appears to compact 
the RNA, whereas Bru binding to C RNA displays neither of these two features. These 
substantial differences in binding provide strong support for a basic property of the 
‘instructive substrate’ model to explain the dual action of Bru, namely, that interactions at 
the repressive and activating sequences are distinct and different. While our results do not 
prove that model, they do demonstrate that no additional factors, such as those posited in 
the ‘binding partners’ model, are required to create differences in the binding of Bru to 
the repressive and activating substrates. In addition, the discovery that cooperative 
binding to the AB RNA does not involve protein dimerization, but instead depends on the 
RNA and correlates with an apparent change in RNA structure, provides evidence that 
the RNA dictates how Bru will bind, the key feature of the ‘instructive substrate’ model. 
Are the differences in binding of Bru to AB and C important for the decision to 
repress or to activate?  
At present we are unable to determine if the observed differences in Bru binding 
to the AB and C regions dictate whether Bru will repress or activate translation. The 
mutations in the AB region that reduce cooperativity and disrupt the apparent compaction 
associated with Bru binding also substantially reduce the affinity of binding. Thus any 
defect in repression observed when the RNAs are tested for their effects on translation 
could be due either to reduced binding or to qualitatively altered binding (or both).  
Although we cannot yet design an experiment that would demonstrate that 
cooperativity and RNA restructuring are important for repression by Bru, a simple 
experiment might disprove this notion. We know that addition of the AB region to an 
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otherwise unregulated reporter mRNA leads to its repression (see Chapter 3), and this 
assay could be modified to target Bru to the mRNA via a different RNA binding protein. 
Specifically, the reporter mRNA could be modified by addition of multiple binding sites 
for the bacteriophage MS2 coat protein (Nagai, 1996), and an RNA binding defective 
form of Bru (Harrison et al., unpublished) could be expressed as a fusion to MS2 coat 
protein.  
Our experiments with altered forms of the AB RNA do lead to one very strong 
conclusion. Gunkel et al previously used the sAB mutant to argue that binding of Hrp48 
to the AB region is important for repression (Gunkel et al., 1998). They presented 
evidence that the sAB RNA retained strong Bru binding (as measured by a UV 
crosslinking assay), yet was defective in repression. Because the mutant RNA had 
substantially reduced Hrp48 binding, they concluded that binding of Hrp48 is important 
for repression.  Our quantitative binding data clearly show that the sAB RNA has 
dramatically reduced affinity for Bru (Kd of 1 uM), and so the observed defects in 
repression are expected simply from loss of Bru binding. Although there is genetic 
evidence that reduction of Hrp48 activity affects osk mRNA translation (Yano et al., 
2004), this may or may not involve binding of Hrp48 to the osk mRNA. 
Specificity of Bru binding sites  
Bru appears to be relatively selective in its action. There are three known or 
suggested substrates: osk mRNA, grk mRNA and cycA mRNA (Filardo and Ephrussi, 
2003; Kim-Ha et al., 1995; Sugimura and Lilly, 2006; Webster et al., 1997). Although 
this may not represent all target mRNAs, Bru does not bind to many control RNAs used 
in binding assays.  
Bru binding sites appear to have relatively low complexity. A BRE as originally 
defined contains 7 nt, U(G/A)U(A/G)U(G/A)U (Kim-Ha et al., 1995). Bru is very closely 
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related to EDEN-BP and Bru-3, with ~60% identity in amino acid sequence within the 
RRM RNA binding motifs (Delaunay et al., 2004; Paillard et al., 1998; Webster et al., 
1997). This suggests that the proteins may have very similar binding specificities. Indeed, 
EDEN-BP and Bru-3 bind to repeated copies of the tetranucletides UGUA and/or UAUG 
(Delaunay et al., 2004; Paillard et al., 1998). These tetranucleotides appear within the 
BRE sequence, and are highly enriched in the osk AB and C regions, and may thus 
comprise the basic Bru binding site. If the Bru binding site is indeed such 
tetranucleotides, then binding sites for Bru are expected to appear in random sequences 
every 256 nt (or 128 nt if both tetranucleotide sequences bind Bru), and should be present 
in effectively all mRNAs. How then would Bru display specific binding, and how would 
its action be limited to only a subset of mRNAs? Part of the answer seems clear: strong 
binding probably requires a local concentration of the tetranucleotides. The unusual 
behavior of Bru in binding to the AB region raises the possibility that repression may 
require that multiple copies of the basic binding sites be presented in a particular 
organization, perhaps to promote cooperativity and/or restructuring upon binding. If so, 
then an ‘active’ arrangement of Bru binding sites might have an extremely low 
probability of occurring in random sequences. Further characterization of the binding of 
Bru to the other substrates, from the grk and cycA 3’ UTRs (Filardo and Ephrussi, 2003; 
Sugimura and Lilly, 2006; Webster et al., 1997), should help clarify this issue. 
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MATERIALS AND METHODS 
RNA preparation and purification 
All radiolabled RNAs were prepared by in vitro transcription of cloned templates 
containing appropriate fragment of the osk 3’UTR, and subsequently purified on a 
denaturing RNA acrylamide gel followed by a protocol from Ambion (Technical Bulletin 
#171). The template for both AB and A probes was generated previously by subcloning 
an EcoRI-DraI fragment from osk 3’UTR into pSP72 vector (Kim-Ha et al., 1995) (DNA 
template was linearized with BglII and ApaLI for transcription of AB and A RNA, 
respectively). The B template was generated by subcloning an ApaLI-DraI fragment into 
pSP73 (DNA template was linearized with DraI for transcription of B RNA). The A+B- 
template was generated by replacing the ApaLI-DraI fragment of AB(BRE+) with the 
equivalent fragment from AB(BRE-) (Kim-Ha et al., 1995) (DNA template was 
linearized with BglII for transcription of A+B- RNA). The sAB template (Gunkel et al., 
1998) was generated by PCR (primers: 5’-cgggatccgtagtatgttctctgtctttg-3’ and 5’-
gaagatctcaataatatacaataatggactag-3’) and subcloned into BamHI and BglII sites of 
pGEM2 (DNA template was linearized with SacI for transcription of sAB RNA). The C 
template was generated by PCR (primers 5’-tctggatccttctggcgtaatttacagc-3’ and 5’-
tcggatcccagttactttgaacatagc-3’) and subcloned into pSP72 as an XbaI (a native site on the 
osk 3'UTR) and BamHI fragment (DNA template was linearized with BamHI for 
transcription of C RNA). 
Protein constructs and purification 
For expression of 6xHisBru and 6xHisBru 334-416, wild type Bru coding 
regions was generated by joining two fragments, NdeI (start codon)-EcoRV fragment by 
 115 
PCR (primers: 5’-ccgaattcatatgttcaccagccgcgctt-3’ and 5’-ccgaattctagcgttcattgcgattctcgc-
3’) and EcoRV-EcoRI (stop codon) fragment from a bru cDNA clone (Webster et al., 
1997). It was then subcloned into pET15b (Promega) as an NdeI-EcoRI fragment for 
6xHis fusion at the N terminus. The Bru 334-416 coding region was generated from by 
deleting 83 amino acids from the full length Bru coding region using two unique 
restriction sites, PflMI and NotI, followed by blunt end ligation. 6xHisBru and 
6xHisBru 334-416 were expressed in Codonplus RP and pLysS E. coli (Stratagen), 
respectively. The bacteria were grown to ~0.7 optical density (measured at 600 nm), and 
induced by addition of IPTG to 1 mM. 6xHisBru was induced at room temperature for 6 
hrs because of its insolubility. 6xHisBru 334-416 was induced at 37°C for 3 hrs. 
Bacteria cultures were collected as pellets in 50 mL Falcon tubes by centrifugation at 
5000g in the cold. Pellets were frozen at –20°C and thawed on ice on the next day. Pellet 
from 50 mL of culture was resuspended in 5 mL Histag Binding Buffer (20 mM 
phosphate buffer pH 7.8, 500 mM NaCl, 10% glycerol, 1xProtease Inhibitors (500 uM 
pefabloc (Boehringer Mannhelm), 2.5 mM benzamidine, 10 ug/mL pepstatin, and 10 
ug/mL leupeptin), 20 mM Imidazole). Resuspended culture was sonicated on ice and cell 
debris was pelleted in a glass tube at 4000g for 15 min at 4°C. The supernatant was saved 
as lysate and kept on ice until loading onto a purification column. A purification column 
was made by packing 1.5 mL Prebond Histag Resin (Invitrogen) in a 3 mL clinical 
syringe. It was then assembled onto a Biorad ECONO Gradient Pump in the cold room. 
The column was pre-washed with dH2O for 20 mins and then Histag Binding Buffer for 
another 20 mins (1 mL/min, same below). Lysate was loaded onto the column and the 
following gradient program was used for purification: 10min/0%B, 20min/0-100%B, 
10min/100%B (A-20 mM Imidazole in Histag binding buffer; B-300 mM Imidazole in 
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Histag binding buffer). About 40 1 mL fractions were collected using a Biorad Fraction 
Collector (Model 2110). 
Aliquots of each fraction (20 μl) were run on a SDS-PAGE followed by 
coomassie staining to determine the peak fractions. Peak fractions were pooled and 
concentrated by dialysis against 25% PEG (MW 15-20,000 PEG in 25 mM Tris pH 7.5, 1 
mM EDTA, 200 mM KCl) followed by dialysis against 1x GMS Binding Buffer (10 mM 
Tris-Cl pH 8.0, 25 mM NaCl, 0.1 mM EDTA, 1x protease inhibitors, 10% glycerol) 
overnight. Protein concentrations were determined by UV spectroscopy using NanoDrop  
(NanoDrop Technologies). Extinction coefficients for 6xHisBru and 6xHisBruDA were 
estimated by the method of Gill and von Hippel (available at 
http://us.expasy.org/tools/protparam.html). Proteins were then diluted with 1x GMS 
Binding Buffer to 10 uM for use as a 10x stock. 
Electrophoretic gel mobility shift assays and data analysis 
The complex between protein and RNA was visualized by gel mobility shift 
assay. The assay was carried out as described (Ryder et al., 2004) with some 
modifications. The final equilibration reactions contain 1x GMS Binding Buffer, 0.1 
mg/mL tRNA, 5 ug/mL heparin, 0.5% NP-40, 50 ug/mL BSA, 200 pM radiolabeled RNA 
and protein concentrations ranging from 0 to 1000 nM. The RNA was heated to 55°C for 
5 mins and cooled at room temperature for 5 mins. Total reaction volumes were 20 uL. 
Reactions were kept at room temperature for 2 hours. During the same period of time, a 
native polyacrylamide gel (6% w/v 37.1:1 acrylamide/Bis-acrylamide, 0.25xTBE, 0.75 
mm thick) was pre-run at 400V in the cold room also for 2 hours. Before loading, 4 ul of 
loading dye (30% v/v glycerol, 0.05% w/v xylene cyanol) was added to each sample. A 
portion (10 uL) of each reaction was loaded onto the pre-run gel and continued to run at 
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400V for another 3 hrs in the cold room. Gels were dried and exposed to a 
PhosphorImager screen overnight (Molecular Dynamics).  
Data were quantified using ImageQuant software (Molecular Dynamics) and the 
fraction of bound RNA was determined as Bound%=Bound/(Free+Bound) for each 
protein concentration. Bound% was plotted against protein concentration using 
KaleidaGraph (v4.0). Apparent dissociation constants (Kd) for titration of RNA with 
protein were determined using the equation y=m0^m2/(m0^m2+m1^m2), where y is the 
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Figure 4.1. Bru binds differently to osk AB and C regions. 
A. A diagram of the osk mRNA. The osk coding sequence is shown as a thick dark bar. 
AB and C regions (also RNAs) are shown as thin dark bars right above a thin dark line 
representing the osk 3’UTR. Diagram is not drawn to scale. B. Binding of Bru to 
radiolabeled AB RNA monitored by gel mobility shift assay. Migrating positions of free 
AB RNA and the Bru/AB RNA complex are labeled as Free and Bound on the right, 
respectively (same below). Bru protein concentrations range from 0-1000 nM (1:1 
dilution series, see Materials and Methods). Each lane corresponds to the following Bru 
concentrations (from left to right, same to all gel panels): 0, 1.95, 3.9, 7.81, 15.62, 31.25, 
62.5, 125, 250, 500, 1000 nM. Plot of the fraction of AB RNA bound versus the 
concentration of Bru are also shown. Data were fit using non-linear least squares analysis 
as described in Materials and Methods. Kd is 39 nM and Hill Coefficient is 1.7, 
indicating positive cooperativity. Note that Bru accelerates AB RNA to a faster migrating 
position comparing to free AB RNA. C. Binding of Bru to radiolabeled C RNA 
monitored by similar gel mobility shift assay as in B. The data were also analyzed the 
same way as described in B. Kd is 126 nM and Hill Coefficient is 1.1, indicating non-
cooperative binding. In contrast to AB RNA, binding of Bru retards the migration of C 






Figure 4.2. A complete AB region is required for all features of Bru binding. 
A. A diagram of wild type AB RNA and four modified RNAs: sAB, A, B and A+B-. 
Dark box indicates a BRE. Diagram is not drawn to scale. Details about these five RNAs 
are described in Results or Materials and Methods. B. Binding of Bru to radiolabled 
RNAs in gel mobility shift assays. RNAs used in the assay are indicated on the left. Kds 
for each Bru/RNA interactions are shown on the right. Bru concentration in each lane is 
the same as in Fig 4.1. 
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Figure 4.3. Bruno dimerization is not required for cooperative binding to the AB RNA. 
A. A diagram of wild type Bru and dimerization-defective mutant Bru 334-416 (Bru  in 
the figure and below). Dark box indicates a RRM. B. Binding of Bru or Bru  to 
radiolabeled AB RNA monitored by gel mobility shift assay. Both panels in B are from 
the same native gel. Data were plotted in B. Bru/AB RNA binding – Kd is 45.7 nM and 
Hill Coefficient is 2.0. Bru /AB RNA binding – Kd is 112.5 nM and Hill Coefficient is 
3.2. Note that Bru  can still bind to AB RNA cooperatively. Each lane corresponds to the 
following Bru concentrations (from left to right): 0, 3.9, 7.81, 15.62, 31.25, 62.5, 125, 
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